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Abstract 
 
 
Vesicular stomatitis virus (VSV) is an enveloped, nonsegmented, negative-sense, 
RNA virus belonging to the Rhabdoviridae family.  VSV is considered the prototypic 
Rhabdovirus due to its simple genetic organization, broad host cell tropism, and ability to 
be easily grown in cell culture.  Therefore, VSV has been used as the prototype to study 
viral entry, transcription, replication, and assembly.  Viral entry, a critical step in the 
lifecycle of the virus, is mediated by the outer surface protein, G and will be the focus of 
this dissertation.  
 
We hypothesize that the highly conserved residues in the membrane-proximal 
region of VSV G protein are critical to membrane fusion through participation in low pH-
induced conformational changes and stability of theses structures.  This hypothesis was 
tested initially through the use of site directed mutagenesis and then by studying rapidly 
acquired second site mutations.  Residues that are conserved completely or conserved for 
their biochemical properties were either deleted or mutated to alanines.  The mutated G 
proteins were examined through the use of transient transfection assays for their surface 
expression levels, fusion capacity, and ability to undergo pH dependent conformational 
changes.  Mutation of a conserved HPH motif (H423/P424/H425) resulted in a dramatic 
decrease in surface expression.  ΔH423/P424/H425 was completely fusion defective as 
assessed by syncytium formation assays that measured cell-cell fusion.  Likewise, the 
cell-cell fusion activity for ΔH425 was affected in that the pH threshold required to 
trigger the fusion event was decreased.  These findings support previous reports 
suggesting a requirement for histidine protonation in order for the pH dependent 
conformational changes needed for membrane fusion to occur.  Recombinant viruses 
encoding the mutated G proteins were recovered and all of the viruses expressing G 
proteins with reduced cell-cell fusion capacity, as compared to wild type, grew to lower 
titers, with the exception of one mutant: D435A/D436A/E437A.  Mutation of the DDE 
motif resulted in a G protein with a reduced capacity to fuse in transiently transfected 
cells.  However, recombinant virus encoding D435A/D436A/E437A was recovered and 
unexpectedly grew to wild type titers, suggesting that the virus is overcoming the fusion 
defect caused by the mutation.  Wild type VSV virions have been shown to express a 
truncated G protein on their surface, called G-stem (GS).  GS was detected on the virion 
of this mutant at levels higher than that of wild type suggesting the truncated G protein 
was contributing to enhancing the infectivity of the virus. 
 
Mutation of conserved phenylalanines (F440A/F441A) also resulted in a similar 
phenotype as the ΔH425 mutant.  Reduced surface expression was observed when this 
mutated G protein was transiently expressed in cells and a decrease in the threshold pH 
required for fusion was also observed.  Recombinant VSVs encoding the mutated G 
proteins were recovered to analyze the impact of the mutations on the ability of the 
viruses to grow and spread.  Interestingly, viruses encoding the ΔH425 and the 
F440A/F441A mutant G proteins rapidly acquired additional mutations that made the 
viruses better able to grow and spread as indicated by increased titers and plaque sizes.  
Plaque isolates were obtained and subjected to sequence analysis revealing several 
vi 
variants: ΔH425/S438I, ΔHI426S/S438I, F440V/F441A, F440T/F441A, 
F440A/F441A/S438I, and F440A/F441A/CT9.  To identify the advantage the additional 
mutations were providing the recombinant viruses (if any), the mutations were cloned 
into expression vectors and the mutant G proteins were examined for their surface 
expression levels and fusion capacity.  The mutations appeared to enhance cell surface 
expression levels, with the exception of the ΔH425/S438I and F440A/F441A/CT9 
mutants.  The F440A/F441A mutants still were reduced in cell-cell fusion activity at pH 
6.0 as compared to wild type G.  However, the ΔH425 mutants’ fusion activity was 
partially restored at pH 6.0.  Results from these experiments suggest that when both the 
ΔH425 and F440A/F441A mutant G acquire a S438I mutation the fusion capacity at pH 
6.0 is restored.  The findings in these studies indicate residues in the membrane-proximal 
region of VSV G are critical to the fusion process, suggesting a likely contribution to the 
stabilization of the pre- and postfusion structures.  
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Chapter 1: Introduction 
 
 
Enveloped Viruses: Host Cell Entry 
 
  Vesicular stomatitis virus (VSV) is an enveloped, nonsegmented, single-
stranded, negative sense RNA virus in the Rhabdoviridae family.  VSV serves as the 
prototypic Rhabdovirus due to its broad host range, simple genetic organization, and 
ability to be easily grown in cell culture.  VSV has been used as a tool to better 
understand various phases of enveloped viral life cycles.  The focus of this work will 
primarily be the role of the outer surface protein (G) in membrane fusion and viral entry.  
In particular, the studies are aimed at examining the contribution of the membrane-
proximal region of G in virus-cell membrane fusion.  All enveloped viruses must undergo 
a fusion event with the host cell membrane for successful entry.  Enveloped viruses have 
evolved various mechanisms to achieve the common goals of membrane fusion and host 
cell entry, as will be discussed further. 
 
 
A Brief Introduction to Enveloped Viruses.  Enveloped viruses are made up of a host 
cell derived lipid membrane surrounding their nucleocapsid, with glycoproteins 
embedded in this outer membrane.  A common feature of all enveloped viruses is the 
need for viral membrane fusion with a host cell membrane enabling the release of the 
viral genetic information into the cell cytoplasm.  Fusion is mediated by the glycoproteins 
(or fusion proteins) protruding from the envelope of the virus.  Viruses have evolved 
many means by which to enter host cells to initiate cycles of replication to further spread.  
Fusion can either take place between the outer membrane of the host cell or an endocytic 
membrane (Smith and Helenius 2004; Earp, Delos et al. 2005).  Fusion between the viral 
membrane and a host membrane is either pH independent or pH dependent.  Some 
viruses, such as measles virus (Paramyxovirus), can bind and fuse at the cell surface, 
while other viruses such as influenza virus and VSV hijack the host cell endocytic 
pathway for entry into the cell (Helenius and Kartenbeck 1980; Matlin, Reggio et al. 
1982).  Fusion for viruses, such as VSV,  that utilize the endocytic pathway is triggered 
by the drop in pH in the endosome or processing by proteases that are active at low pH 
within the endosome, while the viruses that fuse at the cell surface do not require a low 
pH trigger, but instead rely on receptor or receptor/co-receptor recognition.  Information 
presented here will be focus mechanisms of enveloped virus entry mediated by viral 
fusion proteins. 
 
 
Viral Fusion Proteins. Envelope fusion proteins are responsible for receptor recognition, 
host cell entry, and in some cases, play a role in egress from the host cell.  Viral envelope 
proteins have been widely studied in an effort to better elucidate the life cycle of 
important human pathogens, such as influenza virus, HIV-1, and Ebola virus.  Viral 
fusion, as previously mentioned,  is a process by which the viral membrane and a host 
cell membrane are brought into close proximity, leading to lipid mixing, formation of a 
fusion pore, and finally release of the viral genetic information into the host cell cytosol.  
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Although viral fusion proteins vary widely in their structures and mechanisms of action, a 
few common features are seen (Hernandez, Hoffman et al. 1996).  Fusion proteins are all 
similar in that they are type I transmembrane proteins which are made up of a large 
ectodomain, a single transmembrane spanning domain, and a cytoplasmic tail.  Other 
commonalities include; they are all trimers and they all have a fusion peptide, which is a 
short hydrophobic or non-polar sequence that is required for mediating fusion (White, 
Delos et al. 2008).  All fusion proteins undergo large conformational changes that drive 
this process. These large scale changes in conformation provide the needed free energy 
for mixing of two lipid bilayers, which is an energetically expensive event.  In fusion 
proteins studied thus far, the basic mechanism allowing for membrane mixing, resulting 
in fusion pore formation and transfer of the nucleocapsid in to the cytosol, is through the 
formation of a hairpin structure in the final conformation of the protien (Kielian and Rey 
2006).   
 
 Fusion proteins have been divided in two well characterized groups (class I and 
class II) (Lescar, Roussel et al. 2001) based on the structural features and transitions 
leading to virus-host-cell fusion (Table 1-1).  Some examples of viruses with class I 
fusion proteins are Coronaviruses, Filoviruses, Arenaviruses, Orthomyxoviruses, 
Paramyxoviruses, and Retroviruses (Skehel and Wiley 1998; Eckert and Kim 2001; 
White, Delos et al. 2008).  Influenza virus HA is the prototypic class I fusion protein, 
while the fusion proteins from Alphaviruses and Flaviviruses make up class II fusion 
proteins.  Recent structural determination of the glycoprotein (G) from vesicular 
stomatitis virus (Roche, Bressanelli et al. 2006; Roche, Rey et al. 2007) and one of the 
fusion proteins from herpes simplex virus, gB,  (Heldwein, Lou et al. 2006) has led to the 
identification of class III fusion proteins.  The next section will discuss the similarities 
and differences in the three classes of fusion proteins by describing prototypic members 
of each.   
 
 
Three Classes of Viral Fusion Proteins 
 
 
Class I Viral Fusion Proteins.  Class I viral fusion proteins all share common structural 
and functional characteristics in their fusion mechanisms.  One key feature common to 
the class I viral fusion proteins is a refolding event that occurs during the fusion process.  
In the prefusion state, class I fusion proteins are present as trimeric spikes on the virion 
surface.  Proteolytic cleavage is required for these proteins to mature to the prefusion 
form.  Cleavage of the envelope protein can occur in the low pH environment of the 
endosome, or during maturation of the protein.  Triggering of fusion leads to the 
rearrangement of a highly stable rod-like structure with a central α-helical coiled-coil, 
which is termed the pre-hairpin intermediate.  A key feature among this class of viral 
fusion proteins is the positioning of the fusion peptide, which is initially buried in the 
trimer interface.  Initial triggering of fusion allows for formation of the pre-hairpin 
intermediate which exposes the fusion peptide and allows for insertion of the fusion 
peptide into the target membrane.  While in this intermediate conformation the protein is 
in an extended form in which the C-terminal transmembrane domain and the fusion 
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Table 1-1. Characteristics of class I and class II fusion proteins. 
 
   
          Class I Features                                                            Class II Features 
 
 
Conformational change from a  Conformational change and  
metastable trimer to a stable trimer oligomeric rearrangement from a 
during fusion metastable dimer to a stable  
 trimer   
 
Secondary structure is primarily Secondary structure is  
α-helical predominantly β-sheet 
 
Post fusion structure is a trimer of Post fusion structure is a trimer  
hairpins with a central α-helical of hairpins primarily made up of 
coiled-coil (6-helix bundle) β-sheets 
 
Proteolytic processing of fusion Proteolytic processing of a  
protein required to mature to the companion protein required for  
pre-fusion state maturation to the pre-fusion state 
 
In the metastable pre-fusion state In the metastable pre-fusion state 
the fusion peptide is N-terminal the fusion peptide is located at   
and buried in the trimer interface the fusion protein tip and is  
 capped by dimer interaction  
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peptide are at the opposite ends of the molecule. The next step in the conformational 
change is the formation of a hairpin structure in which the C-terminal transmembrane 
domain and the fusion loops are brought into close proximity.  Formation of the hairpin 
structure pulls the viral and host cell membranes together for the fusion event to occur. 
Some class I viral fusion proteins include: the S2 protein from SARS; the HA protein of 
the influenza A and B viruses; the F1 protein from PIV-5; and gp41 from HIV-1.  The 
first viral fusion protein to be extensively studied was that of Influenza virus (HA) 
(Wiley, Wilson et al. 1981; Wilson, Skehel et al. 1981).  From these studies began the 
understanding of a general pathway that enables membrane fusion.  I will next discuss the 
means by which Influenza virus HA protein mediates membrane fusion to serve as an 
example of a typical class I protein. 
 
 
Influenza Virus HA.  Influenza virus belongs to the Orthomyxoviridae family and is a 
segmented, negative strand, enveloped, RNA virus.  Embedded in the envelope are three 
types of surface protein, NA, HA, and M2.  HA has both receptor binding and fusion 
activity, both of which are necessary for entry of influenza into host cells. 
 
Initially HA0 protein is synthesized as uncleaved monomers that must fold 
correctly and trimerize for proper trafficking through the secretory pathway to the cell 
surface (Gething, McCammon et al. 1986). HA0 is a trimer with a large globular head 
domain that is made up primarily of  two subunits, HA1 and a long α-helical coiled-coil 
stalk region (Chen, Ariel et al. 1988).  Host cell proteases cleave the precursor protein 
HA0 into two disulfide bonded subunits, HA1 and HA2.  After cleavage, the overall 
structure of HA is nearly unchanged except the N-terminal fusion peptide becomes buried 
in the trimer interface within the α-helical stalk.  HA1 binds the receptor and is present on 
the virion surface in a metastable state, while HA2 is the transmembrane subunit (also in 
a metastable state) that contains the fusion peptide and is required for membrane fusion.  
 
 HA1 binds sialic acid-containing receptors on the host cell surface (Wiley and 
Skehel 1987).  The virion is internalized into the host cell through endocytosis as is 
observed in VSV infection (Maeda and Ohnishi 1980; Huang, Rott et al. 1981; White, 
Matlin et al. 1981).  As the pH drops in the endosome to around 5 or 6 (Daniels, Downie 
et al. 1985), HA undergoes an irreversible conformational change from the prefusion 
metastable state to a low pH conformation (Bullough, Hughson et al. 1994) (Fig 1A).  
This irreversible conformational change contrasts with the reversible change observed in 
the VSV G fusion protein.   
 
First, HA1 trimer contacts at the head domains are dissociated with the low pH 
induced conformational change.  This initial conformational change releases the fusion 
peptide from its buried position and projects it toward the target membrane, where it 
irreversibly inserts (Bullough, Hughson et al. 1994).  At this stage the protein is anchored 
in the target membrane by the fusion peptide and anchored in the virion membrane by the 
transmembrane domain, thereby forming the pre-hairpin intermediate.  The next step in 
the conformational change is the movement of the long α-helix of HA2 folding  
5 
Cell Membrane
Virus Membrane
Virus Membrane
Cell Membrane
A
B
 
 
 
Figure 1-1.  Class I and class II mediated fusion schematic.  (A)  A schematic 
representing HA mediated membrane fusion (class I).  HA protein (prior to cleavage) is 
present as trimers on the virion surface.  Large conformational change occurs after 
exposure to low pH exposing the fusion peptide leading to insertion into the target 
membrane.  The fusion protein folds back on itself forming the six helix bundle and 
pulling the two membranes together for membrane merger (Skehel and Wiley 2000). (B)  
A Schematic representing class II mediated membrane fusion, as shown by SFV E. SFV 
E1 (yellow) and E2 (purple) are initially present on the virion surface as dimers.  
Exposure to low pH causes dissociation and exposure of the fusion loop.  Low pH and 
presence of cholesterol in the target membrane triggers insertion of the fusion loop and 
alignment of the E1 subunits, favoring trimerization.  E1 folds back on itself pulling the 
two membranes together leading to initial lipid mixing (hemifusion), which then 
progresses to full fusion. (Kielian and Rey 2006).  
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downward, reversing the direction of the membrane proximal segment of HA2, in effect 
pulling the two opposing membranes together (Bullough, Hughson et al. 1994).  The 
postfusion conformation of HA2 is a highly stable rod with the transmembrane domain 
and the N-terminal fusion peptide at the same end of the molecule forming a trimer of  
hairpins (also referred to as a six-helix bundle)(Eckert and Kim 2001).  Membrane fusion 
in class I viral fusion proteins is driven by the energy that is released during the 
conformational changes from the metastable, prefusion form to the stable post fusion 
form (Ruigrok, Wrigley et al. 1986; Carr, Chaudhry et al. 1997; Melikyan, Markosyan et 
al. 2000; Russell, Jardetzky et al. 2001).  Structural analysis of other fusion proteins 
revealed unique features from what was seen in Influenza virus HA protein, which led to 
the grouping of a second class of fusion protein, that will now be discussed.   
 
 
Class II Viral Fusion Proteins.  Class II fusion proteins differ in several ways from their 
class I counterparts.  Viral glycoproteins in the Alphavirus and Flavivirus families are 
initially present on the virion surface as dimers.  Although the ectodomains of these 
proteins do not share much sequence homology, their secondary and tertiary structures 
are very similar (Lescar, Roussel et al. 2001).  Secondary structures of class II fusion 
proteins are primarily made up of β-sheets (Kielian and Rey 2006; White, Delos et al. 
2008).  Classs II fusion proteins differ from class I fusion proteins in that they require a 
regulatory protein to fold properly that is later cleaved by the cellular protease, furin, late 
in the secretory pathway.  This cleavage is a critical regulatory step for viral entry 
(Wengler and Wengler 1989; Salminen, Wahlberg et al. 1992; Stadler, Allison et al. 
1997; Zhang, Wang et al. 2003).  After cleavage of the regulatory protein, class II fusion 
proteins undergo an oligomeric rearrangement in which the dimers dissociate and 
reorganize into trimers, a process triggered by low pH in the endosome (Wahlberg, Bron 
et al. 1992; Allison, Schalich et al. 1995).   When the dimers dissociate, the fusion 
peptide becomes exposed and inserts into the target membrane.  A key difference 
between class I and class II fusion proteins is the location of their fusion peptide.  Class II 
fusion proteins have an internal fusion peptide while the class I fusion proteins have a 
fusion peptide that is located N-terminally. The presence of cholesterol in the target 
membrane is needed for insertion of the fusion peptide into the target membrane in 
Alphaviruses (Kielian, Keranen et al. 1984; Nieva, Bron et al. 1994) and enhances 
membrane insertion in Flaviviruses (Corver, Ortiz et al. 2000; Stiasny, Koessl et al. 
2003) as shown by liposome experiments. Insertion of the fusion peptide lines up the 
fusion proteins in a manner such that trimerization is favored.  The protein then folds 
back on itself positioning the transmembrane domain and the fusion loops near one 
another and pulling the two membranes together.  Semliki Forest virus E1 protein is a 
well characterized example of a class II fusion protein that will be described in further 
detail. 
 
 
Semliki Forest Virus E1 Mediated Fusion.  Semliki Forest virus (SFV) is a small, 
enveloped, positive strand RNA virus whose fusion is mediated by E1 glycoprotein 
embedded in the viral membrane.  E1 is organized into three domains with the major 
secondary structure being β-sheets, a key feature of class II fusion proteins (Lescar, 
7 
Roussel et al. 2001; Roussel, Lescar et al. 2006).  Domain I (DI) begins at the N-terminus 
of E1 and has one end connected to two long extensions in Domain II (DII) with the other 
end is connected to domain III (DIII) by a linker region. One extension is the fusion loop 
while the other extension is the ij loop, which is closely associated with the fusion loop at 
the DII tip.  Domain III connects to the stem region, which leads to the transmembrane 
domain, and contains an immunoglobin-like fold (Gibbons, Reilly et al. 2004).  
 
An interesting feature of SFV E1 is that it actually lies tangential to the virus 
membrane in its native state (Fig 1-1B).  E1 is present as a heterodimer in a complex with 
E2, the receptor binding subunit, at the virion surface.  Initially, the fusion peptide is 
hidden by E2 when in the complex.  As the pH drops in the endosome, a conformational 
change in the E1/E2 heterodimer occurs, causing dissociation of the complex, which in 
turn exposes the fusion peptide (Fig 1-1B).  The next step in the process leading to fusion 
of the virus membrane with the endosomal membrane is the insertion of the fusion loop 
into the target membrane.  Insertion of the fusion loop is dependent upon the presence of 
cholesterol in the target membrane (Kielian, Keranen et al. 1984; Nieva, Bron et al. 
1994).  Once the fusion loop interacts with the target membrane the E1 monomers are 
aligned and reorganized into trimers. Once the monomers have formed trimers they fold 
back on themselves forming a hairpin.  Formation of the hairpin structure is dependent 
upon domain III and the stem region folding back on the fusion loop.  The stem region 
has been shown to be important to E1 mediated virus-membrane fusion (Liao and Kielian 
2006), which will be discussed at greater length later in this chapter.  Vesicular stomatitis 
virus G does not completely fit into either of these previously characterized classes of 
fusion proteins and therefore, a third class of fusion proteins will be discussed. 
 
 
Class III Viral Fusion Proteins.  Fusion glycoproteins from the Rhabdovirus and 
Herpesvirus families do not fit into either class I or class II fusion proteins.  A key 
characteristic that separates class I and class II fusion proteins is the location of the fusion 
peptide.  Class I fusion proteins have an N-terminal fusion peptide, whereas the fusion 
peptide in class II fusion proteins is internal. Class III fusion proteins appear to have 
qualities seen in both classes of viral fusion proteins.  One commonality between these 
fusion glycoproteins and those from class I and II is the use of conformational changes to 
drive the formation of a hairpin oligomeric structure to pull the two opposing membranes 
together. Class III glycoproteins are initially present as trimers and remain trimers after 
the conformational change during virus-cell fusion, which is seen in class I fusion 
proteins.  Like class II fusion proteins, these proteins have β-sheets as their major 
secondary structure, however, they also have α-helices as seen in class I fusion proteins.  
Class III fusion proteins also have internal fusion loops like class II.  It is not known if 
Rhabdoviruses and Herpesviruses fit into one class alone or if they vary widely enough 
from one another that they cannot be classified together.  One possibility is that the less 
well characterized mechanisms for fusion in these proteins all essentially function in the 
same manner.  However, viruses such as Herpesviruses and Poxviruses use a number of 
viral glycoproteins to fuse with target membranes.  This complexity indicates that there 
may be much about the fusion processes that has yet to be determined.  Vesicular 
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stomatitis virus is the prototypic Rhabdovirus and serves as a good model to study fusion 
mechanisms of viruses in which less structural information is available. 
 
 
Vesicular Stomatitis Virus.  Vesicular stomatitis virus (VSV) is a prototypic member of 
the Vesiculovirus genus and Rhabdoviridae family.  VSV is a small, enveloped virus with 
a single molecule of negative sense RNA as its genetic material.  The virion has a bullet 
shaped morphology typical to Rhabdoviruses, and is approximately 180 nm long and 75 
nm wide.  VSV has been used as a prototypic virus to study entry, replication, and 
assembly due to its simple genetic organization, ability to be easily grown in cell culture, 
and broad host cell tropism.  While VSV does not normally infect humans, the virus 
infects livestock and farm animals causing vesicular lesions on the hooves, teats, and 
gums.  Vesicular stomatitis viruses are classified into two major serotypes: New Jersey 
and Indiana.  These two serotypes share approximately 50% glycoprotein amino acid 
sequence homology (Rose and Whitt 2001).  Other serotypes of VSV include 
Chandipura, Cocal, Piry, and Isfahan.  VSV’s antisense, 11Kb genome encodes five 
major proteins; the nucleocapsid (N), phosphoprotein (P), matrix (M), glycoprotein (G), 
and large polymerase (L).  In addition to the 5 structural proteins, C and C’ are 
synthesized from an alternative reading frame in the P mRNA (Spiropoulou and Nichol 
1993).  Two other proteins (M2 and M3) are N-terminal truncation mutants (Jayakar and 
Whitt 2002). 
 
The focus of this dissertation is the entry of VSV, which is initiated by the 
binding of the envelope protein, G, to an unknown host cellular receptor.  Identification 
of the receptor for VSV G has been challenging due to the broad cell tropism of the virus.  
Initial studies using proteolytic digestion of the cell surface did not inhibit VSV infection, 
indicating the receptor is not likely a protein.  Furthermore, the receptor was shown to be 
soluble in chloroform-methanol and was sensitive to phospholipase C, indicating the 
binding activity involves phospholipids (Schlegel, Willingham et al. 1982).  Incubation 
of VSV with purified phosphatidyl serine resulted in an 80-90% decrease in VSV plaque 
formation (Schlegel, Willingham et al. 1982).  The authors concluded the host cell 
receptor was likely phosphatidylserine (PS).  Other reports suggested that VSV binding 
to cells is mediated by electrostatic interactions (Carneiro, Bianconi et al. 2002).  The 
most recent findings, published in 2004, claim that the experiments indicating 
phosphatidyl serine is the receptor for VSV could not be reproduced.  Experiments in this 
report indicated the level of PS on the cell surface had no affect on VSV infection or 
binding to cells.  Furthermore, when cells were incubated with annexin V, which 
specifically binds PS on the cell surface, VSV binding and infection was still detected.  
Addition of PS to the cells enhanced VSV infection, but was not necessary, indicating PS 
is not the receptor but may be important to a step in the entry pathway post binding (Coil 
and Miller 2004).  
 
Following cellular receptor binding, VSV is internalized into clathrin-coated 
endosomes (Matlin, Reggio et al. 1982).  Fusion of the virus envelope with the 
endosomal membrane occurs as the pH drops to around 6.2 to 6.3 (the threshold pH for 
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fusion of VSV G).  Once fusion occurs, the nucleocapsid containing the VSV genome is 
released into the cytoplasm where replication occurs. 
 
Approximately 1200 molecules of G are present on the virion surface, and these 
are organized into 400 trimeric spikes (Thomas, Newcomb et al. 1985).  G is a typical 
type I transmembrane protein that is embedded into the viral envelope with a short 
cytoplasmic tail of 28 to 29 amino acids, a 20 residue transmembrane domain, and a large 
antigenic ectodomain of 446 amino acids (Rose, Welch et al. 1980; Rose, Doolittle et al. 
1982).  The VSV virion is made up of two components, the ribonucleoprotein (RNP) 
core, and the membrane envelope.  The ribonucleoprotein core contains a single copy of 
the negative-sense RNA genome encapsidated in a tight complex with about 1,200 
molecules of the nucleocapsid protein (N).  The L (large catalytic subunit) and P 
(phosphoprotein) proteins make up the RNA-dependent RNA polymerase which is also 
associated with the RNP.  The L and P proteins are present in about 50 and 500 
molecules, respectively in the virion (Thomas, Newcomb et al. 1985).  The M protein 
must be removed for uncoating of the viral genome.  This protein also plays a role in 
assembly of progeny virions as well as budding from the host cell membrane.  
Approximately 1800 molecules of matrix protein are inside the viral envelope between 
the membrane and the nucleocapsid core.  Although this work focuses on the entry of 
VSV a brief discussion of VSV replication will follow to give a complete description of 
the viral life cycle. 
 
 
Replication of VSV.  Viral replication of VSV occurs entirely in the host cell cytoplasm 
following entry.  The viral genome is released into the cytoplasm and undergoes 
uncoating (Rigaut, Birk et al. 1991; Lyles and McKenzie 1998).  Uncoating is a process 
by which the M protein dissociates from the RNPs causing decondensation of the RNP 
cores.  Recent studies in our lab support a model in which the uncoating process is 
coupled to virion membrane fusion with the endosomal membrane.  When the pH drops 
in the early endosome, VSV G undergoes a conformational change which mediates 
fusion.  At this time, G also mediates the acidification of the virion interior which is 
suggested to affect the interaction between the membrane bound and the RNP bound M, 
leading to the release of the RNP into the host cell cytosol for replication (Mire 2008).  
The encapsidated RNA genome then is used as a template for the RNA-dependent RNA 
polymerase mediated transcription.  Transcription is initiated at the 3’ end of the genome 
and is sequential and polar as with other nonsegmented negative-sense RNA viruses.  
Each of the five genes is transcribed in the order in which is appears from the 3’ end of 
the gene (Iverson and Rose 1981; Iverson and Rose 1982; Lyles and McKenzie 1998).  
These viral mRNAs then serve as templates for the synthesis of the viral proteins.   The 
viral mRNAs are capped, methylated and polyadenylated by the RNA polymerase 
(Schubert, Keene et al. 1980; Hercyk, Horikami et al. 1988).  Once enough N protein is 
made the leader is encapsidated.  Replication of the viral genome then ensues, allowing 
for synthesis of the full-length positive sense replicative intermediate (RI).  The RI is 
encapsidated and serves as a template for the synthesis of the genome.  The newly made 
genomic RNA is encapsidated by the N protein to form the RNP.  N protein is thought to 
associate with G protein in the plasma membrane.  The M protein is recruited to the 
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budding site leading to association with the nucleocapsid (Lyles and Swinteck 2008).  
The cores then bud through the host cell plasma membrane with the G proteins embedded 
within, forming new progeny virions.  Further rounds of infection then ensue with the 
binding of the G protein to the next host cell, internalization, and fusion.  The next few 
sections will focus more specifically on the G protein of VSV. 
  
 
Vesicular Stomatitis Virus Glycoprotein.  G protein is synthesized on the rER, is 
transported to the cell surface via the secretory pathway, and is localized to the host cell 
membrane.  The glycoprotein is synthesized as a 511 amino acid precursor with a 16 
amino acid signal peptide that is cleaved during transport into the ER.  G has widely been 
used to study protein folding and protein transport through the secretory pathway, 
therefore much is known about its folding and maturation process (Doms, Keller et al. 
1987; de Silva, Balch et al. 1990; de Silva, Braakman et al. 1993). While in the ER, the 
glycoprotein of VSV Indiana receives two N-linked oligosaccharides at positions 179 and 
336.  The G protein of the Indiana serotype is palmitoylated at a cysteine residue in the 
cytoplasmic tail, but this modification has been shown not to impact function of the 
protein (Whitt, Buonocore et al. 1991).  As G is being translated, the ectodomain of G 
associates with ER chaperones, BiP (Machamer, Doms et al. 1990) and calnexin 
(Mathieu, Grigera et al. 1996).  This association helps in proper folding and formation of 
disulfides in the ER.  Once the G protein monomers are properly folded, they form non-
covalently associated homotrimers.  Formation of homotrimers is essential for the 
exocytic transport of G (Doms, Keller et al. 1987; Doms, Ruusala et al. 1988).  
Interestingly, VSV G trimers have a unique quality in that they are unstable and there is 
constant dissociation and reassociation of monomers that occurs both in the ER and on 
the cell surface (Zagouras, Ruusala et al. 1991; Zagouras and Rose 1993). Soluble forms 
of G, lacking the transmembrane and C-tails were constructed and were able to form 
trimers when expressed in cells, indicating the region responsible for trimerization lies 
within the ectodomain (Crise, Ruusala et al. 1989).  Trimerization of VSV G has been 
proposed to be stabilized by the M protein (Lyles, McKenzie et al. 1992) as shown by 
incubating purified M protein or M protein associated with nucleocapsid protein with G 
and using resonance energy transfer to detect association of subunits.  Since all fusion 
proteins in their active form have trimeric quaternary structure, it stands to reason that 
stabilization of VSV G trimers is critical to the productive entry of the virus.  VSV entry, 
as mentioned above, is the focus of this work, so the next sections will address various 
aspects of membrane fusion and viral entry. 
 
 
pH Dependent Conformational Changes.  One limitation to the full understanding of the 
fusion process previously has been the fact that no structural information was available 
for G.  VSV G adopts at least three different conformational states of which two of these 
structures have recently been published (Roche, Bressanelli et al. 2006; Roche, Rey et al. 
2007) (Fig 1-2A and B).  One unique feature of VSV G is the reversible nature of the pH 
dependent conformational changes.  There is a pH dependent equilibrium between the 
pre- and post fusion conformations that is shifted toward the postfusion conformation 
when exposed to low pH (Roche and Gaudin 2002).  In both class I and class II mediated  
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Figure 1-2.  Crystal structures of VSV G.   (A) Crystal structure of VSV G in its 
prefuison state.  G sits on the virion surface like a tripod with the fusion loops shown in 
green (located in the fusion domain, yellow) extending toward the virion.  Domain I, in 
red, is the lateral domain.  Domain II (blue) on the interior is the trimerization domain.  
Orange represents the pleckstrin homology (PH) domain, III.  Reprinted with permission 
from  Roche, S., F. A. Rey, et al. (2007). "Structure of the prefusion form of the vesicular 
stomatitis virus glycoprotein G." Science 315(5813): 843-848.  (B) G in its post fusion 
form is represented using the same color scheme to identify each domain.  All the 
domains undergo dramatic change in their orientation and position but retain their 
original folds except domain III which refolds.  Reprinted with permission from Roche, 
S., S. Bressanelli.  et al. (2006). "Crystal structure of the low-pH form of the vesicular 
stomatitis virus glycoprotein G." Science 313(5784): 187-191. 
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fusion, the glycoproteins are in a metastable state initially and upon the fusion trigger 
undergo irreversible conformational changes to a more stable form. The prefusion 
structure of VSV G is made up of four distinct domains (Roche, Rey et al. 2007).  
Domain I is referred to as the lateral domain, while domain II is the trimerization domain 
that likely functions to supply the interactions needed to form G trimers.  Domain III is 
called the pleckstrin homology domain (PH) and may likely serve for host cell binding 
due to the PH domain’s capability to bind phosphoinositides (Harlan, Hajduk et al. 1994; 
Bottomley, Salim et al. 1998; Rebecchi and Scarlata 1998; Lemmon and Ferguson 2000).  
Domain IV is the fusion domain, containing the fusion loops that are required for 
membrane fusion and consequently, host cell entry.  
 
Membrane proteins are difficult to crystallize due to their amphiphillic character 
and the fact that they must be kept soluble by detergents throughout the entire 
purification and crystallization process.  Therefore, to avoid this dilemma, the G protein 
was cleaved with thermolysin generating a truncated G in which the membrane proximal 
region was not included.  The focus of the work described in this dissertation is to better 
understand the role of the membrane proximal region of G protein in host cell entry.  
Since no structural data exists, theses studies employed a mutagenesis approach to 
examine the contribution of this region to the fusion process.  In the prefusion 
conformation, G sits on the viral membrane in the shape of a tripod with the C-terminal 
segment extending out from the viral membrane (in a manner that is yet unknown).  The 
fusion loops are kept apart and serve as the legs of the tripod.   
 
Class I and class II fusion proteins are different in that their hydrophobic 
segments are buried at an oligomeric interface in the prefusion conformation while the 
fusion loops of G are exposed.  Once exposed to low pH a dramatic structural 
rearrangement occurs.  Within the lateral domain and the trimerization domain is a rigid 
block (RbI-II) that remains constant between pre- and postfusion conformations.  In the 
transition between the prefusion conformation to the postfusion conformation, the fusion 
domain and the C-terminal segment flip relative to the RBI-II.  Both fusion loops and the 
transmembrane (TM) domain move ~160Å from one end of the molecule to the other.  
Domains I, III, and IV retain their folded structure during this dramatic reorganization of 
the protein.  Proposed intermediates in the structural transitions position the fusion loops 
in proximity to the target membrane in which they are able to insert.  The final step in the 
conformational changes after the insertion of the fusion loops is the formation of the 
trimer of hairpins in which the two opposing membranes are brought into close proximity 
allowing for full fusion.   
 
As mentioned previously, G is unique in that the conformational changes are 
reversible.  The crystal structure of the low pH conformation was solved through P408, 
with a histidine at position 407.  Based on the crystal structures the authors suggested that 
H407 participates in a salt-bridge with D137, in the fusion domain, that likely stabilizes 
the post fusion structure (Roche, Bressanelli et al. 2006).  Although the structures of G in 
the prefusion and low pH conformations have provided a wealth of information as to the 
fusion mechanism, many questions still remain.  Intermediates in the conformational 
changes have yet to be identified and also the membrane-proximal region is not included 
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in any structures, thereby leaving gaps in the understanding of the participation of this 
region.  Studies of other membrane-proximal regions of fusion proteins have given 
insight as to an overall possible mechanism of action, but since VSV differs in the 
structural transitions from the better understood class I and class II fusion proteins further 
work must be done to understand the role of the membrane-proximal region.  As 
mentioned, the crystal structure revealed a histidine residue that is likely important for 
stabilization of the post fusion structure.  Histidine protonation has been suggested to be a 
key step in pH dependent viral fusion as will be discussed further. 
 
 
Role of Histidine Protonation in pH Dependent Conformational Changes.  Although 
VSV G differs in the structural transitions seen with class I and class II fusion proteins, 
one commonality is the requirement of a fusion trigger.  Some viruses within each group 
of fusion proteins require exposure to low pH for host cell entry.  Interestingly, low pH 
induced fusion generally occurs at a pH close to the pKa of histidine in water (pKa = 6), 
strongly suggesting the protonation of one or more residues may drive the conformational 
changes.  As mentioned above, the crystal structure reveals H407 likely participates in a 
salt bridge with D137 further supporting this hypothesis.  Studies have indicated that 
protonation of histidines in other viral fusion proteins may drive the pH dependent 
conformational changes.  Analysis of sequences from Influenza virus and Flavivirus 
envelope proteins, respectively, revealed a number of highly conserved histidine residues 
(Kampmann, Mueller et al. 2006).  When histidines are buried within the protein, a lower 
pH is required for protonation, which could account for lower pH requirements for fusion 
proteins such as seen in dengue virus (pH for fusion is 5) (Heinz and Kunz 2004).  Most 
recently, Margaret Kielian’s group identified a histidine residue (H3) in Semliki Forest 
virus that is required for the structural transitions that lead to fusion (Qin, Zheng et al. 
2009).  Five histidine residues were mutated to alanines with the one mutation at residue 
3 resulting in reduced growth and a decrease in the pH required for membrane fusion.  
Dissociation of the heterodimer was not affected but the formation of E1 homotrimers 
required a decrease in pH from that of wild type.  Speculation as to the role of histidines 
in the low pH induced conformational changes seen in VSV G arose well before the 
crystal structures were solved.  In fact, chemical modification of histidines in G abolished 
cell-cell fusion.  When the chemical treatment was reversed, VSV G mediated fusion was 
restored (Carneiro, Stauffer et al. 2003).  Together these findings strongly suggest that 
the protonation of one or more histidine residues drives low pH induced conformational 
changes required for VSV G mediated membrane fusion.  The next sections will 
specifically focus on membrane-proximal regions of viral fusion proteins and the possible 
contribution of this region in the G protein to membrane fusion. 
 
 
Membrane-Proximal Regions of Viral Fusion Proteins 
 
The membrane-proximal segments of various viral fusion proteins have highly 
hydrophobic characteristics and are often rich in tryptophan residues.  In the final post 
fusion conformation, the membrane-proximal regions of viral fusion proteins are in close 
proximity with both membranes as well as in a position to possibly interact with the 
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fusion domains (or fusion loops).  Reports have suggested the membrane-proximal 
regions of HIV-1 gp41, (Salzwedel, West et al. 1999), Semliki Forest virus E1 (Liao and 
Kielian 2006), and VSV G (Jeetendra, Robison et al. 2002; Jeetendra, Ghosh et al. 2003), 
may have a mechanistic role in membrane fusion (virus entry).   
 
 
HIV-1 gp41 Mediated Fusion.  To understand the contribution of the membrane 
proximal region (MPER) of Human immunodeficiency virus (HIV-1), I will first provide 
a general overview of the fusion mechanism.  HIV-1 is an enveloped virus in the family 
Retroviridae, genus Lentivirus, whose host cell entry mechanism has been widely 
studied.  Protruding from the virion envelope are glycoprotein spikes termed env.  HIV 
env is initially synthesized as a fusion inactive protein called gp160.  gp160 is cleaved 
during transport to the cell surface while in the trans-Golgi complex into a non-covalently 
linked heterodimer made up of gp120 and gp41(Hallenberger, Bosch et al. 1992; 
Decroly, Vandenbranden et al. 1994).  Gp120 is the receptor binding portion of the 
protein, while gp41 is the transmembrane segment containing the fusion peptide and is 
necessary for virus-cell fusion (Wyatt and Sodroski 1998).  Gp41 is made up of three 
main domains, the ectodomain, membrane spanning domain, and the cytoplasmic tail.  
Within the ectodomain are the fusion peptide and two heptad repeats, one at the N-
terminus and one at the C-terminus, and the membrane-proximal external region 
(MPER).  The MPER is a tryptophan rich region located N-terminally to the 
transmembrane domain (Salzwedel, West et al. 1999). 
 
HIV-1 binds to a target cell via gp120 by utilizing a CD4 receptor (Maddon, 
Dalgleish et al. 1986) and a chemokine co-receptor (Lapham, Ouyang et al. 1996; Trkola, 
Dragic et al. 1996; Wu, Myszka et al. 1996; Berger 1998).  Unlike Influenza HA, Semliki 
forest virus E, and VSV G, HIV env mediated fusion until recently has been believed to 
be pH independent (Stein, Gowda et al. 1987; Maddon, McDougal et al. 1988; McClure, 
Marsh et al. 1988).  Recent evidence supports another model of entry in which HIV-1 
enters via receptor mediated endocytosis and fuses within the endosome with the help of 
the cellular protein, dynamin (Miyauchi, Kim et al. 2009).  This report indicated that only 
lipid mixing occurred at the plasma membrane whereas productive entry occurred via the 
endocytic pathway.  Furthermore, due to the low levels of HIV-1 env on the virion 
surface (Zhu, Liu et al. 2006) it stands to reason the virus may need the additional help of 
cellular proteins to overcome the energy barrier leading to the membrane merger event.  
However, this model still indicates the need for the receptor/co-receptor binding.  This 
initial receptor and co-receptor binding leads to a dramatic conformational change that 
exposes the V3 loop of gp120 (Choe, Farzan et al. 1996; Wu, Myszka et al. 1996).  The 
initial conformational changes allow the glycoptrotein to interact with the chemokine co-
receptor.  Final conformational changes are triggered by binding to the co-receptor 
leading to virus-cell fusion (reviewed in Berger, Murphy et al. 1999; Doms and Trono 
2000).  These final conformational changes involve heptad repeats within the fusion 
protein reorganizing to form a six-helix bundle (hairpin structure).  The conformational 
changes result in the hairpin formation that is seen in viral fusion proteins in their post 
fusion conformation.  Like the other proteins described thus far, the TM domain and the 
16 
fusion peptide lie at the same end of the molecule pulling the two membranes together 
(Chan, Fass et al. 1997; Weissenhorn, Dessen et al. 1997).   
 
 
HIV-1 gp41 MPER.  The membrane proximal external region (MPER) of gp41 has been 
shown to play a critical role in efficient incorporation into the viral envelope, as well as 
infectivity of HIV-1 (Salzwedel, West et al. 1999).  The MPER has been predicted 
though computer algorithms to form α-helices and also overlaps at the C-terminal 
sequence of a peptide, DP-178, that has been shown to potentially inhibit fusion and virus 
entry by binding to a portion of the N-terminal heptad repeats (Wild, Dubay et al. 1994).  
An epitope for a neutralizing antibody, 2F5, also lies within this region of the fusion 
protein.  Five tryptophan residues are found within this short hydrophobic sequence that 
are conserved among all sequenced strains of HIV-1, and make up more than 25% of this 
region. Site-directed mutagenesis was used to determine the importance of these residues 
for maturation and virus entry.  When seventeen residues in this region were deleted, cell-
cell fusion was abolished, while maturation of the protein, transport, and binding of CD4 
were not affected.  Substitution of all five tryptophans with alanines also resulted in the 
same phenotype.  Single mutations were made to the tryptophan residues resulting in 
inefficient incorporation and decreased infectivity (Salzwedel, West et al. 1999). 
 
The indole ring in tryptophan residues has been shown to have a strong tendency 
to insert into the membrane-water interface where it disrupts the organization of the 
phospholipids (Reithmeier 1995).  Interestingly, this region can be replaced by a foreign, 
tryptophan rich sequence without significant fusion loss.  These results indicate 
tryptophan residues are key factors in the fusion process.  The work described here, from 
Eric Hunter’s lab, supports the hypothesis that the membrane proximal region of HIV-1 
gp41 utilizes the conserved tryptophans to interact with the target membrane at some 
stage during fusion to allow for fusion pore formation and transfer of viral genetic 
information.   
 
 
Paramyxovirus F Stem.  The stem region of Paramyxovirus fusion proteins have been 
shown to participate in the fusion process by a similar mechanism as was just described 
for HIV-1 gp41.  Paramyxoviruses are enveloped, negative-stranded, RNA viruses.  
Paramyxovirus entry involves two surface proteins, an attachment protein (HN, H, or G) 
and a fusion protein (F).  Viral entry for these viruses occurs at the host cell plasma 
membrane when the attachment protein binds the receptor, activating the F protein for 
membrane fusion (Russell, Jardetzky et al. 2001; Takimoto, Taylor et al. 2002; Corey, 
Mirza et al. 2003; Gravel and Morrison 2003; Porotto, Murrell et al. 2005).  F protein is 
initially synthesized as a precursor protein F0 and is cleaved into a small amino terminal 
subunit, F2, and a carboxy-terminal subunit that is larger, F1.  F protein has two heptad 
repeat regions (termed HRA and HRB) that are both located in the ectodomain of F1.  
HRA is located N-terminally (adjacent to the fusion peptide) while HRB is located 
adjacent to the transmembrane domain.  Studies using peptides directed toward either 
HRA or HRB revealed an inhibition in membrane fusion activity of F protein and 
replication of virus.  The finding that the HRB region (stem region) of the F1 protein is 
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important to the formation of the hairpin structure (Russell, Jardetzky et al. 2001) is of 
particular interest, since the work presented here will be focused on the contribution of 
the membrane-proximal region of VSV G. 
 
 
Semliki Forest Virus E1 Stem.  Another glycoprotein that has been shown to have a 
membrane-proximal region that plays a key role in fusion is that of the SFV E1 protein.  
As mentioned previously, SFV E is grouped into the class II fusion proteins. SFV E is 
cleaved, forming E1, E2, and E3, with E1 containing the fusion peptide.  E1 upon 
exposure to low pH reorganizes to form trimers as the fusion domain is inserted into the 
target membrane.  The trimers undergo further conformational changes leading to the 
formation of the final hairpin structure.  As with other viral glycoproteins, little is known 
about the structure or function of the stem region due to difficulties in crystallizing this 
region of a membrane protein.  However, work has been done using site directed 
antibodies to this region providing some insight as to the role the memrane-proximal 
region might play may play (Liao and Kielian 2006). Polyclonal antibodies were made to 
either the N-or C-terminal halves of the E1 stem and used to identify intermediate 
conformational changes by blocking regions that may interact during the conformational 
changes.  Data has shown that, unlike HIV-1 gp41 MPER, the stem region in E1 is 
thought to play a role in the conformational changes leading to the formation of the final 
trimer of hairpins (Liao and Kielian 2006).  A critical step in the formation of hairpins 
and fusion process is packing of the outer layer of the protein onto the cental core.  It was 
found that the stem was hidden in the neutral pH conformation and became exposed with 
the initial pH induced conformational changes.  The stem then appeared to pack onto the 
trimer core to further the hairpin formation and at this point was once again inaccessible 
to antibody binding.  These data suggested that the membrane-proximal region is 
important in mediating the fusion process, however is not absolutely necessary (Liao and 
Kielian 2006; Liao and Kielian 2006).  The roles of the membrane-proximal regions of 
these fusion proteins provide clues as to the possible contribution of the region in VSV G, 
the focus of this work. 
 
 
VSV G Stem. Since no structural information on the membrane-proximal stem region of 
G exists due to the need for thermolysin cleavage, the role this region plays in fusion has 
been challenging to understand. The carboxy terminus of G has been show to have a high 
degree of sequence homology between vesiculoviruses (Masters, Bhella et al. 1989; 
Gaudin, Raux et al. 1996; Jeetendra, Ghosh et al. 2003).  Among the highly conserved 
residues in the stem region are completely conserved tryptophans.  Substitution analysis 
of these tryptophan residues revealed that, unlike HIV-1 gp41, they are not necessary for 
fusion or budding from the host cell (Jeetendra, Ghosh et al. 2003).  However, the 
membrane-proximal region of G has been shown to enhance the efficiency of VSV 
budding.  Previous studies have shown that VSV can bud in the absence of G, however 
producing about 50-fold less particles (Schnell, Johnson et al. 1997).  Truncation of G so 
that only the C-terminal and transmembrane domains were present indicated further 
requirements for efficient budding, suggesting a role within the ectodomain of G 
(Robison and Whitt 2000).  Another truncation mutant (that will be discussed further in 
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the context of fusion), containing the C-tail, TM domain, and 42 membrane proximal 
amino acids was able to drive near wild type levels of viral budding (Robison and Whitt 
2000).  Further mutational analysis was done by making large insertions or deletions 
within the stem region to identify the impact on membrane fusion or virus infectivity.  
Deletion of the 13 membrane-proximal residues reduced cell-cell fusion and decreased 
virus infectivity by approximately 100-fold (Jeetendra, Ghosh et al. 2003).  Insertions 
and deletions in the membrane-proximal region showed a decrease in fusion activity as 
well as virus infectivity indicating this region plays a role in membrane fusion (Jeetendra, 
Ghosh et al. 2003). 
 
Initial evidence indicating a possible role for the membrane-proximal region of 
VSV G was the development of a truncation mutant, as mentioned above, of G containing 
the C-tail, transmembrane domain, and 42 residues leading up to the transmembrane 
domain (Robison and Whitt 2000).  This mutant was constructed based on a temperature 
sensitive mutant, ts045.  ts045 produces VSV particles lacking the G protein (“bald”) 
when grown at the restricted temperature, 39.5°C (Knipe, Baltimore et al. 1977; 
Zilberstein, Snider et al. 1980).  At this temperature G is misfolded and is retained in the 
endoplasmic reticulum and therefore no G protein can be detected on the surface.  These 
results were used for a long time to show that G protein was not necessary for the 
assembly and budding of the virus.  It was later shown that the “bald” virus particles 
produced by ts045 actually had a short portion of the G protein containing a part of the 
membrane proximal ectodomain, the transmembrane domain, and the cytoplasmic tail 
(Metsikko and Simons 1986).  Robison and Whitt then constructed GS to determine if 
this short region of the ectodomain influenced assembly and budding of VSV.  They 
showed that GS is expressed, forms trimers, is incorporated into the viral envelope with 
high efficiency and can promote wild type levels of budding (Robison and Whitt 2000).  
Therefore, this short region of the ectodomain was shown to contain signals for efficient 
budding.  This mutant has also been studied in the context of viral fusion to further 
understand the role of the membrane-proximal region.  This mutant has been found to 
potentiate the fusion activity of other heterologous viral glycoproteins that do not 
normally fuse on their own (Robison and Whitt 2000; Jeetendra, Robison et al. 2002).  
GS not only potentiates the fusion activity of glycoproteins that fuse at low pH, but also 
those that fuse at neutral pH.  This finding indicates that GS participates in a step in the 
fusion process that is common to both pathways.  Furthermore, GS has the ability to 
induce an active hemifusion state, an indication that GS can interact with and perturb 
membranes (Jeetendra, Robison et al. 2002). 
 
 
Thesis Statement 
 
Recent determination of VSV G crystal structures in the prefusion and low pH 
forms has provided a wealth of information on the fusion mechanism of VSV G.  Not 
only has it helped in identifying possible structural transitions that mediate the fusion 
process, but it has identified another way to achieve cell-virus membrane fusion.  
Previously, viral fusion proteins were grouped into two classes based on their oligomeric 
structure, their predominant secondary structure, the location of the fusion peptide and 
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the presence of a companion protein.  Fusion proteins in each of these groups have 
similar structural rearrangements leading to virus-cell membrane fusion.  Structural 
determination of VSV G and HSV gB has led to the classification of a third group of viral 
fusion proteins that may induce membrane fusion through an alternative pathway to 
achieve the fusion active conformation.  One caveat to the recent developments in 
understanding VSV G mediated fusion is the lack of structural information for the 
membrane proximal region adjacent to the transmembrane domain.  One key feature seen 
in all fusion proteins thus far examined is the formation of a trimer of hairpins that 
functions to pull the two opposing membranes together leading to the membrane merger 
and fusion.  Members of class I fusion proteins, such as HIV-1 gp41 and Influenza HA 
proteins require the membrane proximal region either for the formation of the hairpin or 
for the membrane merger event.  Evidence has also shown the stem region in class II 
fusion proteins, such as Semliki Forest virus E1, plays a role in fusion.  Previous 
mutational analysis has indicated the requirement for the highly conserved membrane 
proximal region in VSV G mediated fusion.  Studies have shown that large insertions and 
deletions affect membrane fusion and virus infectivity, while mutation of the conserved 
tryptophan residues does not appear to have a marked effect.  The work presented here is 
aimed to determine if individual residues in this highly conserved region play a direct 
role in the fusion process and to better understand the contribution of the membrane 
proximal region in VSV G mediated membrane fusion.  We hypothesize that the highly 
conserved residues in the membrane-proximal region of VSV G protein are critical to 
membrane fusion through participation in low pH induced conformational changes and 
stability of theses structures.  In Chapter 3, I will examine the importance of the highly 
conserved residues in the stem region of G in fusion by using site-directed mutagenesis.  
In Chapter 4, I will examine second-site mutations that restored fusion activity in the 
context of the virus to determine the significance of these mutations in surface expression 
and viral fusion.  The results from Chapters 3 and 4 will give insight as to residues that 
may directly participate in the fusion process to better formulate a model for VSV G 
mediated fusion and perhaps contribute further to the understanding of how the 
membrane-proximal regions of other viral fusion proteins participate in the fusion 
process. 
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Chapter 2:  Materials and Methods 
 
 
Mutagenesis 
 
 
Plasmids and Oligonucleotide-Directed Mutagenesis.  The mutated G protein constructs 
were generated using overlapping PCR with pVSV-9.1(+) (Lawson, Stillman et al. 1995) 
as the template.  The sequences of the primers used in generating the mutated G proteins 
are listed in Table 2-1.  The PCR products were generated using conditions as follows; 
95°C  denaturation for 2 minutes, thirty cycles of amplification with 45 seconds at 95°C, 
45 seconds annealing at 50°C, then 72°C for 1 minute, followed by one cycle of 
incubation at 72°C for 7 minutes.  The PCR products were purified on a 6% 
polyacrylamide gel and electroeluted.  The fragments were digested using KpnI and NheI 
restriction enzymes. The fragments encoding mutated G protein were subcloned into the 
pCAGGS-GInd expression vector previously digested with the same enzymes.  Colonies 
were selected and DNA was extracted using an alkaline lysis mini-prep protocol.  The 
DNA was sequenced in both directions using pC-5’MCS 
(TACAGCTCCTGGGCAACGTG) and pC-3’MCS (TAGCCAGAAGTCAGATGCTC).  
Sequencing was performed by the Molecular Resource Center at the University of 
Tennessee Health Science Center.  The mutated G fragment from the pCAGGS 
expression vector was then subcloned into the full length VSV genome, pVSV-9.1 (+) 
(Lawson et al 1995), using KpnI and NheI.  
 
For the F440/F441 mutants that acquired additional mutations, BHK-21 cells 
were infected at an MOI = 1 for 1 hour while rocking at 31°C.  The inoculum was 
removed and replaced with fresh Dulbecco’s Modified Eagles Medium (DMEM) 
containing 5% Fetal Bovine Serum (FBS).  6 hours post infection, RNA extraction was 
performed on the cells.  1 mL of Trizol was added to the cells while rocking at room 
temperature for 5 mins to lyse the cells and the lysates were transferred to 1.5 ml 
eppendorf  tubes.  0.2 ml of chloroform was added, tubes were shaken for 15 seconds and 
incubated at room temperature for 3 minutes.  The samples were centrifuged at 10,000 g 
for 15 minutes, the aqueous phase was collected and transferred to a new tube.  RNA was 
precipitated by adding 0.5 ml of isopropanol and the samples were incubated at room 
temperature for 10 minutes.  The samples were pelleted by centrifugation at 10,000 g for 
10 mins and the supernatant removed.  The pellet was rinsed with 75% ethanol and 
vortexed.  The pellet was air dried and resuspended in 25 µl of nuclease free water.  
Reverse transcription (RT) was performed on the 2 µg of RNA extracted from the 
infected cells using a One-step RT-PCR kit from Quiagen according to manufacturer’s 
instructions.  Primers that were used for the RT and PCR amplification were MW36 
(coding) and 3464 (non-coding) (Table 2-1).  cDNA was digested with NheI and KpnI 
restriction enzymes and subcloned into a pCAGGS-GIND expression vector digested with 
the same enzymes.  Plasmids were sequenced to identify any additional mutations in the 
G gene containing the originally cloned in substitutions or deletions. 
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Table 2-1.  Sequences of primers used in overlapping PCR mutagenesis. 
   
 
     Mutation                          Sense Primer                         Antisense Primer  
 
ΔH423/P424/H425           5’GCTCAGGTGTTCGAAA            5’GTCTTGAATTTCGA 
                                          TTCAAGACGCTGCTTCG3’         ACACCTGAGCCTTTG 3’                                             
 
 
H423A/P424A/H425A     5’AGGTGTTCGAAGCTGCTG      5’GTCTTGAATTACAGC 
                                          CAATTCAAGACGCTGCTT 3’      AGCTTCGAACACCTG 
                                                                                                     AGCCTTTG 3’                                                    
                                          
 
ΔH425                               5’GTGTTCGAACCTCACATT      5’GAATGTGAGGTTCGA      
                                          CAAGACGC 3’                                ACACCTGAGC 3’ 
 
 
H425A                              5’AGGTGTTCGAAGCTCCT         5’GTCTTGAATGTGAGG              
                                          CACATTC 3’                                   AGCTTCGAA 3’ 
 
 
D435A/D436A/E437A    5’CTTCTTGCTGCTGC                  5’ATAAACTAGCAGCA 
                                          TAGTTTATTTTTTGG 3’              GCAGGAAGTTGC 3’ 
 
 
F440A/F441A                  5’GAGAGTTTAGCTGCTG           5’TATCACCAGCAGCTA                            
                                         GTGATACTGGGC 3’                    AACTCTCAT 3’ 
 
 
T444A/G445A                5’GGTGATGCTGCTCTA               5’TTGGATAGAGCAG 
                                        TCCAAAAATCC 3’                         CATCACCAAAAAATA                                    
                                                                                                   AACTCTC 3’ 
 
N449A/P450A                5’CTATCCAAAGCGGCGA           5’CTACAAGCTCGATCG 
                                       TCGAGCTTGTAGAAGG 3’           CCGCTTTGGATAGCCCA                                              
                                                                                                  GTAT 3’ 
 
MW36              5’GTGGATCTCAGCTATCT             
(Outside Primer)             TGCTCC 3’ 
 
 
3464                                                                                           5’CAAACATGAAGAA 
(Outside Primer)                                                                        TCTGGCTAGCA 3’ 
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Surface Expression.  Surface expression of the various G proteins was initially measured 
using indirect immunofluorescence assays.  Approximately 7.5 x 105 baby hamster 
kidney cells (BHK-21) were transfected with a DNA:liposome suspension containing 
2µg of plasmid encoding the respective G mutants and 8µl of lipofectamine (GIBCO-
BRL), according to the manufacturer’s instructions.  Three hours post transfection, the 
media was replaced with DMEM containing 10% FBS and the cells were incubated for 
24 hours at 37°C.   
 
  Following transfection and expression as described above, the cells were fixed 
with 3% paraformaldehyde and processed for indirect immunofluorescence microscopy.  
The cells were probed with a G specific monoclonal antibody, Mab I1 (Lefrancois and 
Lyles 1982), followed by a secondary anti-mouse antibody conjugated to FITC (Jackson 
ImmunoResearch Laboratories, Inc.).  The cells were transfected as previously described 
using 2µg of plasmid DNA and 8µl of Lipofectamine reagent (GIBCO) according to 
manufacturer instructions.  The transfection media was removed and replaced DMEM 
containing 10% FBS and the cells were incubated at 37°C for approximately 24 hours.  
The cells were removed from the plates using PBS containing 50 mM EDTA and pelleted 
by centrifugation at 1250 x g for 5 min.  The cells were fixed in suspension for 10 
minutes in 3% paraformaldehyde at room temperature.  Two washes were done using 
PBS containing 10 mM glycine + 0.05% sodium azide to quench the fixative, then the 
suspension was incubated in PBS-glycine + 0.5% bovine serum albumin (BSA) (Sigma-
aldrich) for 30 minutes at room temperature.  The cells were then probed with a 
monoclonal antibody directed toward G, I1, followed by a secondary goat anit-mouse 
antibody conjugated to FITC.  To quantify cell surface expression, flow cytometric 
analysis was employed.  The cells were analyzed by flow cytometry using an LSRII 
Special Option Flow Cytometer (BD).  BHK-21 cells transfected with empty vector 
(pCAGGS-MCS) were used as a negative control and cells expressing wild type G were 
used as the positive control.  
  
Surface expression was also examined in virally infected cells.  BHK-21 cells 
were plated out to ~90% confluency and infected with the appropriate virus at an MOI=1 
for one hour while rocking at 31°C.  The inoculum was then replaced with DMEM 
supplemented with 5% FBS and the cells transferred to a 37°C incubator with ~ 7% CO2.  
Six hours post infection cells were removed from the dish as described above, fixed and 
stained with I1 followed by FITC secondary antibody for flow cytometric analysis.   
 
 
Initial Characterization of Mutants 
 
 
Cell-Cell Fusion Assays.  BHK-21 cells were transiently transfected as described above 
and approximately 24 hrs post transfection the cells were treated with fusion media 
[(10mM Na2HPO4, 10mM N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid 
(HEPES), 10mM 2-(N-morpholino) ethanesulfonic acid (MES) titrated to the indicated 
pH (e.g. 5.2, 5.5, 6.0, 7.0)] by rinsing one time with fusion media at the appropriate pH, 
then incubating for 1 min at room temperature.  The fusion media was then replaced with 
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DMEM containing 5% FBS and incubated at 37°C for 30 minutes.  The cells were not 
fixed in order to allow for better visualization of polykaryon formation and then 
photographed using phase contrast optics with a 10X objective on a Zeiss Axiophot 
camera and Axiophot software.   Fusion was then quantitated by counting the cells not 
fused in three separate fields of view, and averaging them. Percent of cells fused was then 
determined by subtracting the average number of unfused cells from the average number 
of cells in the plates treated with buffer at neutral pH (unfused).  The number of mutant 
unfused cells was then divided by the number of fused cells and multiplied by 100. 
 
Alternately, BHK-21 cells were infected at an MOI=1 for 1 hour while rocking at 
31°C.  The inoculum was removed and replaced with DMEM containing 5% FBS and 
incubated at 37°C for 6 hours.  At 6 hours post infection, the cells were treated with 
fusion medium as described above then fixed with 3% paraformaldehyde.  Fusion was 
then measured as described. 
 
 
Metabolic Labeling, Transport Kinetics, and Trypsin-Sensitivity Assays.  The assays 
were done as previously described (Fredericksen and Whitt 1995; Fredericksen and Whitt 
1995) with a few modifications.  BHK-21 cells were plated out into 35mm plates at 
~80% confluency and transfected with 2µg of the appropriate plasmid as described 
previously.  Approximately 12 hours post transfection, the cells were rinsed once in 
methionine free DMEM (met-free) and then incubated in 2mls met-free DMEM for 15 
minutes at 37°C.  The media was replaced with 2mls of met-free DMEM containing 
50µCi of [35S] methionine (protein labeling mix, Perkin-Elmer) for various amounts of 
time.  The cells were then either lysed immediately with 1 ml of detergent lysis buffer 
(10mM Tris, (pH 7.4), 66mM EDTA, 1% TX-100, 0.4% deoxycholic acid, 0.02% sodium 
azide) or chased with DMEM + 5% FBS medium containing 2mM excess non-
radioactive methionine and then lysed at the desired times.  The cell lysates were 
centrifuged at 14,000 rpm for 1 min on a table-top microcentrifuge to remove the nuclei 
and cell debris.  Anti-G tail rabbit polyclonal antibody (#3226) was then used as the 
primary antibody for immunoprecipitation as previously described (Whitt, Buonocore et 
al. 1991) except that the post-nuclear supernatants were made to 0.3% sodium dodecyl 
sulfate (SDS) and the primary antibody  incubations were performed at 37°C for 1 hour.  
For transport kinetic studies, one half of the cell lysates were digested with Endo H (New 
England Biolabs) according to the manufacturer’s instructions.  Samples were then 
subject to analysis on a 10% SDS-PAGE gel. 
 
The trypsin-sensitivity assay was performed by labeling BHK-21 cells expressing 
G protein with 35S-methionine (as described above) and then chasing for 1 hour with 
DMEM containing 5% FBS and excess unlabeled methionine.  The cells were then lysed 
in 1x MNT buffer (20 mM MES, 150 mM NaCl, 30 mM Tris, pH 7.5) contatining 1% 
TX-100 at the indicated pH (7.4, 6.1, 5.2).  After removing the nuclei and cell debris by 
centrifugation, the post-nuclear supernatants were incubated with or without TPCK-
trypsin for 30 min at 37°C.  Digestion was halted by adding 100 trypsin inhibitor units of 
aprotonin.  G proteins were then immunoprecipitated by incubating with a polyclonal α-
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VSV antibody followed by Pansorbin.  A 10% SDS-PAGE gel was used to resolve the 
immunoprecipitated G proteins and fluorography was used for visualization.   
 
  
Characterization of rVSV Encoding Mutant G Proteins 
 
 
Recovery of Virus Containing Mutated G Proteins.  Infectious viruses encoding G 
proteins with mutations in the membrane-proximal region were recovered from plasmids 
as described previously (Takada, Robison et al. 1997), with a few modifications (Fig 2-
1).  Approximately 3x 106 baby hamster kidney cells (BHK-21) were infected with a 
recombinant vaccinia virus encoding the T7 RNA polymerase (vTF7-3) (Earl, PL) at an 
MOI of 5 for 1 hour at 31°C.  The inoculum was removed and the cells were transfected 
with a DNA-liposome suspension composed of 5µg of the appropriate pVSV-G mutant 
plasmid and 5µg, 3µg, 5µg, and 1µg respectively, of plasmids containing G, N, P, L 
genes from VSVIND with 76µl of TransfectAce (Rose, Buonocore et al. 1991; Whitt, 
Buonocore et al. 1991).  After 4 hrs, the transfection mix was removed and replaced with 
DMEM containing 10% FBS.  The cells were incubated at 37°C for approximately 48 
hrs.  48 hrs post transfection, the supernatants were harvested and filtered through a 0.2µ 
filter (Millipore, Millex-GS) to remove any residual vaccinia virus.  The filtrate was then 
applied to BHK-21 cells in a 35mm dish that had been transfected with 2µg of pCAGGS-
GIND plasmid 24 hrs earlier.  24-48 hrs later, recovery of the virus was assessed by 
examining the cells for cytopathic effects that are typically seen in a VSV infection.  All 
recombinant viruses were recovered using G-complementation (P1).  200µl of the 
recovery supernatant was used to infect BHK-21 cells without G-complementation to 
produce rVSV expressing the mutated G protein on the surface (P2).  The viruses were 
plaque purified (P3), then passaged on BHK-21 cells to make virus stocks (P4).   
 
 
Plaque Assay.  BHK-21 cells (approximately 5 x 105 cells) were plated into each well of  
a 6 well plate and infected with 10-fold serial dilutions of the virus at 31°C while rocking 
for 1 hour.  The inoculum was removed and the cells were overlayed with DMEM+0.9% 
agar + 5% FBS and incubated at 37°C for 24-48 hours.  Plaques were counted and 
averaged between at least two dilutions.  Virus titers were expressed as plaque forming 
units (PFU)/ml.  To determine plaque sizes, the overlay medium that was added consisted 
of DMEM + 5% FBS + 1.8% methylcellulose.  Approximately 24-48 hours post infection 
the overlay was removed and the cells were washed twice with PBS-glycine.  The cells 
were fixed using 3% paraformaldehyde and stained using α-G I1 monoclonal antibody 
followed by a secondary antibody conjugated to either FITC or rhodamine.  After 
staining the cells, the plaques were imaged using a Zeiss Axiophot epifluorescent 
microscope and Axiophot software.  The plaques were measured for their diameter 
horizontally and vertically.  The diameters for 10 plaques were averaged and the area 
calculated. 
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Figure 2-1.  Schematic representing recovery scheme for rVSV encoding mutated G 
proteins.  BHK-21 cells are infected with vvT7 virus that encodes for T7 RNA 
polymerase at an MOI = 5 for one hour.  The inoculum is removed and the cells are 
transfected with plasmids encoding for N, P, L and G at a 3:5:1:5 ratio for 4 hrs. The 
media is replaced with fresh DMEM containing 10% FBS and the cells are incubated at 
37°C.  Approximately 48 hrs post transfection the supernatants are filtered through a 0.22 
µ filter onto BHK-21 cells transiently transfected with pCAGGS-GIND.  24-48 hrs later 
the cells were observed for cytopathic effects typically seen in VSV infection.  
Supernatants were passaged 3-4 times in the process of obtaining a working stock.  
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 One-Step Growth Curve.   BHK-21 cells were grown to confluency in 35mm plates and 
infected with either wt or mutant viruses at an MOI = 10 for 1 hr at 31°C.  The inoculum 
was removed and the cells were washed three times with serum free DMEM (SF-
DMEM) to remove residual inoculum.  The last wash was replaced with 2 mls of DMEM 
+ 10% FBS and the cultures were incubated at 37°C.  Every 2 hours for 16 hours an 
aliquot of supernatant was removed and the amount of infectious virus was determined 
by plaque assay as previously described. 
 
 
Detection of GS.  To measure the amount of cleaved G protein (GS) present in virions, 
confluent monolayers of BHK-21 cells were infected at an MOI = 1.  At approximately 
16 hours post infection, the supernatant was collected, clarified of cells and cell debris by 
centrifugation at 2500 RPM for 5 minutes and the virus particles were then pelleted by 
ultra-centrifugation at 100,000 x g for 35 min through a 20% sucrose cushion.  The viral 
pellets were resuspended in 100µl of reducing sample buffer and 5µl was loaded on a 
10% SDS-PAGE gel to resolve the proteins. One gel was stained with commassie blue, 
while a duplicate gel was used for western blot analysis.  Samples were transferred to 
PVDF membrane (Millipore), the membrane was blocked in 5% bovine serum albumin 
(BSA) for 30 min at room temperature, and then polyclonal rabbit α-G-tail antibody was 
used as the primary antibody at a 1:500 dilution in blocking buffer and incubated at room 
temperature for 30 minutes.  The blot was then incubated with anti-rabbit antibody 
conjugated to Horseradish Peroxidase (HRP) at a 1:20,000 dilution for 30 minutes.  
Proteins were then detected by treating the blot in HRP detection substrate (Millipore).   
 
 
Selection of Plaque Isolates.  To identify virus variants within the recovery supernatants 
(Fig 2-1), a standard plaque assay was performed as described.  Ten plaques of various 
sizes were selected and removed from the plate using a Pasteur pipette and resuspended 
in 500µl of DMEM containing 5% FBS for 4-5 hours.  The supernatant containing the 
plaque isolate was then was used to infect a 35mm plate of BHK-21 cells at an MOI = 10.  
Approximately 6 hrs post infection the media was removed, RNA was extracted, reverse 
transcribed, PCR amplified using MW36 (forward) and 3464 (reverse) primers  
(Table 2-1), and the resultant cDNA was used for sequencing (as described previously). 
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Chapter 3: Mutational Analysis of the Membrane-Proximal Region of VSV G 
 
 
Introduction 
 
Vesicular stomatitis virus is an enveloped, negative-sense, nonsegmented, RNA 
virus belonging to the Rhabdovirus family and the Mononegavirales order.  Like other 
enveloped viruses, entry into the host cells is dependent upon a fusion event between the 
virus and cell membranes that is mediated by the outer surface glycoprotein, G.  G 
protein attaches to an unknown receptor on the host cell surface (Coil and Miller 2004) 
and is internalized via receptor mediated endocytosis (Matlin, Reggio et al. 1982).  
Fusion of the viral envelope and the host cell endocytic membrane is triggered by the 
decrease in pH within the endocytic environment.  When the pH reaches between 6.2 and 
6.3, initial conformational changes in G are triggered leading to exposure of the fusion 
loops and insertion in to the target membrane.  Further conformational changes then 
occur forming a hairpin structure that pulls the two opposing membranes together.  
Formation of the hairpin (six-helix bundle) structure allows for the initial mixing of the 
outer leaflets of the opposing membranes, which is referred to as hemifusion 
(Chernomordik, Melikyan et al. 1987; Lentz, Malinin et al. 2000).  Once the lipids from 
the outer leaflets have mixed forming the hemifusion intermediate, a stalk is formed in 
which the outer leaflets have collapsed while the inner leaflets remain intact (Jahn and 
Sudhof 1999; Kuzmin, Zimmerberg et al. 2001).  Finally a fusion pore forms at the 
fusion site in which the viral nucleocapsid can possibly pass through or the pore may 
expand further to allow for release into the host cell cytoplasm. Fusion pores have been 
observed through patch-clamp experiments with cells expressing influenza HA 
(Melikyan, Niles et al. 1993; Melikyan, Niles et al. 1993; Zimmerberg, Blumenthal et al. 
1994; Blumenthal, Sarkar et al. 1996).  Regardless of the type of fusion protein or the 
lack of sequence or structural homology, they all undergo a series of conformational 
changes that expose a hydrophobic membrane interacting region (fusion peptide or fusion 
loop) and pull the two membranes together.   
 
The structural rearrangements that VSV G undergoes when exposed to low pH are 
different than what is seen with the well characterized class I fusion proteins, such as 
influenza HA, and are also different from the changes that are observed in members of 
class II fusion proteins.  A key feature that is different in G mediated fusion from the 
fusion proteins grouped in either class I or class II is the reversible nature of the low pH 
triggered conformational changes observed for VSV G.  There is a pH dependent 
equilibrium between the pre- and postfusion conformations that is shifted toward the 
postfusion form when exposed to low pH (Roche and Gaudin 2002).  Prior to 
determination of the 3-dimensional crystal structures of the two forms of VSV G (Roche, 
Bressanelli et al. 2006; Roche, Rey et al. 2007), extensive mutational analysis of G was 
employed to identify regions of the protein that participate in membrane fusion.  A 
putative fusion peptide was identified by mutational analysis and photolabeling 
experiments to residues 118-136 in the VSV G ectodomain.  This region was believed to 
insert into target membranes when exposed to a low pH environment (Whitt, Chong, et 
al. 1989; Li, Drone et al. 1993; Zhang and Ghosh 1994; Durrer, Gaudin et al. 1995; 
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Fredericksen and Whitt 1995).  Deletions and insertions of residues between 395 and 418 
also affected the ability of G to induce membrane fusion (Shokralla, Chernish et al. 
1999).  Furthermore, when double mutants were constructed containing changes to 
residues in both of these regions, fusion was affected in an additive manner, indicating a 
possible interaction between these residues (Shokralla, Chernish et al. 1999).  These data 
were confirmed with the solution of the crystal structures of G in the neutral pH (or 
prefusion) and low pH (or postfusion) conformations (Roche, Bressanelli et al. 2006; 
Roche, Rey et al. 2007).  Interestingly, the structures revealed a unique feature in that 
there were two loops extending toward the viral membrane in the prefusion conformation 
and both of these likely insert into the target membrane upon low pH induced 
conformational changes.  These two loops were proposed to make up a bipartite fusion 
peptide, similar to what has been suggested for the Viral hemorrhagic septicemiavirus 
(Gaudin, de Kinkelin et al. 1999). 
 
To understand the role of the membrane-proximal stem region (MPR) of G we 
employed a mutational analysis coupled with cell-cell fusion and virus infectivity assays. 
Since no structural data exists for the MPR, we chose to mutate charged residues, 
histidines that can form salt bridges with the charged residues (Carneiro, Stauffer et al. 
2003; Roche, Rey et al. 2007), or highly conserved residues. We initially characterized 
the mutated G proteins based on surface expression and cell-cell fusion capacity.  Those 
mutant G proteins with cell-cell fusion phenotypes different from that of wild type were 
examined for their ability to undergo pH dependent conformational changes.  We also 
recovered recombinant virus encoding mutated G proteins to examine the effects of the 
mutations on the infectivity of the virus. 
 
 
Results 
 
 
Mutagenesis of the Membrane-Proximal Region of G.  To investigate the role of the 
membrane-proximal region of VSV G we employed a mutational analysis, focusing on 
highly conserved residues as well as residues that are conserved for their chemical 
properties.  Available sequences from VSV-Indiana San Juan strain, (Rose and Gallione 
1981), VSV New Jersey (Gallione and Rose 1983), Chandipura virus (Masters, Bhella et 
al. 1989), Cocal virus (Bhella, Nichol et al. 1998), Isfahan virus (Marriott 2005), Piry 
virus (Brun, Bao et al. 1995), and spring viremia of carp virus (SVCV) (Lecocq-
Xhonneux, Thiry et al. 1994) were aligned, revealing several completely conserved 
amino acids as shown in yellow (Fig 3-1A) .  Several residues in this region are 
completely conserved, while others are functionally conserved based on their chemical 
properties as depicted with turquoise color.  Many residues in this region were also 
conserved for their chemical properties and are represented with a green background.  
Some interesting features within this region are the conserved HPH motif (H423, P424, 
and H425) as well as the conserved acidic residues D435, D436, and E437.  Residues 440 
and 441 are conserved among the closely related vesiculoviruses in the alignment, with 
phenylalanines at both positions.  In the New Jersey serotype G these two positions a 
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Figure 3-1.  Sequence alignment of closely related vesiculoviruses and mutations 
made. (A) Sequences from various strains of vesiculoviruses were aligned using Vector 
NTI Software (Alignx), to identify residues in this region of the protein that are 
completely or highly conserved.  The strains of vesiculovirus shown are from VSV 
Indiana (Rose and Gallione 1981), VSV New Jersey (Gallione and Rose 1983), 
Chandipuria virus (Masters, Bhella et al. 1989), Cocal virus (Masters, Bhella et al. 1989; 
Bach, Bringmann et al. 1990; Bhella, Nichol et al. 1998), Isafan virus (Marriott 2005), 
Piry virus (Brun, Bao et al. 1995), and spring viremia of carp virus (SVCV) (Lecocq-
Xhonneux, Thiry et al. 1994).  Residues with a yellow background represent 
conservation among all of the vesiculoviruses aligned. Residues with a turquoise 
background are almost completely conserved with only one exception and residues with a 
green background are those with similar biophysical properties.   (B) Mutations that were 
made to the G protein from the Indiana serotype (San Juan strain) are shown. 
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tyrosines, which strongly resemble phenylananine in that they both are bulky, strongly 
hydrophobic, and contain a conjugated ring system.  T445 and G446 were completely 
conserved as were N449 and P450, suggesting a possible role for these residues in the 
function of the protein.  Two tryptophan residues are completely conserved in this 
sequence alignment.  Studies with HIV-1 env revealed a key role for conserved 
tryptophans in both env mediated membrane fusion and virus budding (Salzwedel, West 
et al. 1999).  Theses two conserved tryptophans in VSV G residues were previously 
mutated to determine their importance for entry and budding, but surprisingly, these 
experiments revealed no critical role in either process (Jeetendra, Ghosh et al. 2003). 
 
To examine the contribution of the conserved residues in the membrane proximal 
region to the fusion activity of G protein, I made substitutions and deletions (Fig 3-1B).  
The HPH motif was deleted (ΔH423-H425) as well as replaced with alanines 
(H423A/P424A/H425A).  H425, individually, was also deleted or replaced with an 
alanine.  D435-E437 was mutated to alanines as were F440/F441, T445/G446, and 
N449/P450.  These mutants were initially characterized for surface expression, fusion 
capacity, and the ability to undergo low pH induced conformational changes.  
 
 
Surface Expression of VSV G Mutants.  To determine if the mutations affected the 
transport from the ER to the Golgi or cell surface expression of the mutant G proteins, 
Endo H resistant assays and flow cytometry were performed on cells expressing each of 
the mutants.  BHK-21 cells were transfected with plasmids expressing either wild type or 
mutant G proteins and the cells were processed for indirect immunofluorescence 
microscopy using a G specific mAb (I1) (Lefrancois and Lyles 1982) as an initial screen 
for surface expression.  The initial screen indicated that all the mutated G proteins were 
expressed on the cell surface, but the G proteins with mutations made to the HPH motif 
appeared to be expressed at lower levels than that of wild type G protein (data not 
shown).  Flow cytometry was then used to quantify the levels of surface expression and 
the surface expression was described as relative florescence intensity based on the 
percent of cells expressing G and the mean fluorescence intensity of those cells (Fig 3-2).  
Deletion of H423- H425 or substitution of all three residues to alanines resulted in a 
dramatic decrease in surface expression of the G protein to ~20% that of wild type levels.  
However, the single mutation of H425 to an alanine resulted in a protein that was 
expressed at levels ~70% that of wild type. Substitution of D435-E437 with alanines 
resulted in near wild type levels of expression, while F440A/F441A showed a reduction 
in surface expression to ~35% that of wild type levels.  When T445-G446 and N449-
P450 were mutated to alanines the levels of surface expression was also similar to wild 
type (Fig 3-2).  Flow cytometric data from those mutants with a reduced level of surface 
expression (ΔHPH, H423A/P424A/A425A, ΔH425, and F440A/F441A) revealed that 
approximately 50% of the cells were expressing G as determined by the percent parent 
cells expressing.  However, the mean fluorescence intensity was greatly reduced as 
compared to wild type, explaining the relative fluorescence intensity amounts described 
above (Table 3-1).  These results indicate that the cells transfected with plasmids 
encoding the G proteins with mutations to the HPH or FF motifs were expressing the     
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Figure 3-2. Cell surface expression of glycoprotein mutants.  BHK-21 cells were 
transiently transfected with 2µg of plasmid encoding the indicated G protein.  
Approximately 24 hr later, cells were prepared for flow cytometry using a monoclonal 
antibody directed to G (I1) and a secondary antibody conjugated to FITC.  Expression 
levels represent relative surface expression.  Relative surface expression = (% positive 
cells in mutant population x mean fluorescence intensity) / (% WT positive cells x WT 
mean fluorescence intensity).  Values are expressed as a percentage of WT surface 
expression, which was set at 100%.  Averages of three separate experiments were 
calculated with standard deviations shown. 
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Table 3-1.  Percent parent expressing cells and mean fluorescence intensity values. 
 
 
           Protein                                      Percent Parent                      Mean Fluorescence 
                                                                                                            Intensity 
 
 MCS 0.5% 1036 
 Wt G 87.7% 10950 
 H423A/P424A/H425A 38.2% 2722 
 ΔH423/P424/H425 45.4% 3296 
 ΔH425 51.4% 4957 
 H425A 73.7% 9646 
 D435A/D436A/E437A 77.7% 9657 
 F440A/F441A 57.5% 5617 
 T445A/G446A 88.4% 10320 
 N449A/P450A 77.1% 10849 
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protein but at significantly lower levels than what is observed for wild type.  Since these 
proteins appear to be expressed at lower levels, the next step in characterization is to  
determine whether these mutants are able to be transported from the ER to the Golgi and 
if so, the rate at which this occurs. 
 
 To examine the transport kinetics of the mutant G proteins that showed greatly 
reduced cell surface expression as compared with wild type G, Endoglycosylase H (Endo 
H) analysis was used (Fig 3-3).  While in the ER, G (or other membrane bound or 
secreted proteins) acquire high mannose oligosaccharides.  At this stage in the secretory 
pathway, the proteins are sensitive to Endo H digestion.  The protein then moves from the 
ER to the medial Golgi where the high mannose oligosaccharides are cleaved by Golgi 
mannosidase II, resulting in complex oligosaccharides that are resistant Endo H 
digestion.  Acquisition of Endo H resistance, therefore can be used to compare rates at 
which the mutated proteins migrate from the ER to the Golgi, or if they do at all.  The 
ΔH423/P424/H425 and H423A/P424A/H425A mutants acquired EndoH resistant sugars 
more slowly than wild type and after 60 minutes were still not entirely resistant to 
digestion.  H423A/P424A/H425A does not have a band in the treated or untreated lane at 
the 15 minute time point likely due to an inefficient transfection (the treated and 
untreated samples for each time point came from one plate of transfected cells).  Since 
complete Endo H resistance was not observed even after 60 minutes, the lack of protein 
in the 15 minute samples does not impact the interpretation of the data. The transport 
kinetics of ΔH425 and F440A/F441A were more similar to that of wild type in that by 30 
minutes these proteins were completely resistant to Endo H digestion, but perhaps 
slightly reduced in rate based on the amount of resistance at 15 minutes.  From this 
experiment it appears that, surprisingly, ΔH425 and F440A/F441A are moving from the 
ER to the medial Golgi at a similar rate as compared to wild type.  This finding is 
particularly surprising for the ΔH425 mutant that is reduced in surface expression by 
~80% from that of wild type. The next step in the characterization of the mutated G 
proteins is to examine the fusion capacity through the use of a syncytium formation 
assay. 
 
   
Cell-Cell Fusion Activity of Mutants.  The functionality of these mutated G proteins was 
examined based on the premise that fusion proteins can be transiently expressed in cells 
and mediate cell-cell fusion.  Syncytium formation can then be observed as a means by 
which to quantify the fusion capacity of a protein.  Likewise, cells can be infected with 
virus and treated with fusion media to observe syncytium formation.  BHK-21 cells 
expressing either wild type G protein or the mutants individually were treated with fusion 
media buffered to pH 6.0 or 7.0 as an initial screen for fusion capacity.  A separate plate 
of cells transfected in parallel was used for flow cytometry to quantify the level of cell 
surface expression for the experiment.  Cell-cell fusion was not observed for several of 
the mutants.  The ΔH423/P424/H425, ΔH425, H423A/P424A/H425A, F440A/F441A, 
and D435A/D436A/E427A mutants all showed no cell-cell fusion based on a lack of 
syncytium formation in the plates treated at pH 6.0 (data not shown).  All of these  
35 
 
 
 
Figure 3-3. Transport kinetics of mutants with reduced surface expression.  BHK-21 
cells were transfected as described in figure 3-2.  Approximately 12 hr later, the cells 
were metabolically labeled with 35S-methionine, chased with medium containing excess 
non-radioactive labeled methionine for the times indicated, and immunoprecipitated 
using a polyclonal α-VSV antibody (TN-1).  The precipitated proteins were then digested 
with Endo H and analyzed on a 10% SDS-PAGE gel. 
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mutants, with the exception of D435A/D436A/E437A, were expressed at lower levels 
than wild type on the cell surface as assessed by flow cytometry (data not shown).   
 
Based on the reduced cell surface expression, two possible conclusions could be 
drawn.  It has previously been suggested for rabies virus that approximately 13 to 19 
trimers are needed at the fusion site to cause membrane coalescence (Roche and Gaudin 
2002), and therefore, a decreased amount of protein on the cell surface could prevent 
fusion from occurring.  Alternatively, the mutations, while important to proper folding 
and surface expression, may also affect a critical step in the fusion process.  To examine 
these possibilities, BHK-21 cells were transfected using varying amounts of plasmid 
expressing wild type G and mutant G proteins such that the surface expression levels of 
wild type was less than or equal to that of the mutants.  The cells were treated with fusion 
media buffered to pH 5.2, 5.5, 6.0, or 7.0 to also examine the possibility that the 
mutations may have resulted in a decrease in the threshold pH required for fusion.  
   
Interestingly, the ΔH423/P424/H425 mutant when expressed on the cell surface at 
a level greater than that of wild type, showed no cell-cell fusion activity at any of the pHs 
examined (Fig 3-4).  These data indicated that ΔH423/P424/H425 is a fusion defective 
mutant.  Analysis of the ΔH425, D435A/D436A/E437A, and F440A/F441A mutants, 
(when expressed on the cell surface at levels greater than that of wild-type) revealed 
minimal fusion at pH 6.0 as compared with wild type G protein (Fig 3-5A).  These results 
indicate that the ΔH425, D435A/D436A/D437A, and F440A/F441A mutants have a 
reduced pH threshold for fusion.  H423A/P424A/H425A was expressed at a lower level 
than wild-type in all experiments so conclusions on the fusion capacity could not be 
drawn. To quantify cell-cell fusion in these experiments, cells that had not fused in three 
separate fields of view were counted, averaged, and subtracted by the number of cells 
unfused in the plates that had been treated with neutral pH buffer.  These data further 
confirmed a reduced threshold for cell-cell fusion activity that was initially observed for 
the ΔH425, D435A/D436A/E437A, and F440A/F441A mutants.  Likewise, the 
ΔH423/P424/H425 mutant was completely fusion defective at each pH examined. 
 
 
 Analysis of pH Dependent Conformational Changes.  Since several mutants showed 
defects or a reduction in fusion activity, I wanted to determine if these mutants could 
undergo pH dependent conformational changes.  It has been shown that VSV G in the 
prefusion form is sensitive to trypsin digestion and as the pH decreases the protein 
becomes more resistant to digestion (Fredericksen and Whitt 1996).  Acquisition of 
trypsin resistance is believed to be a result of the large scale conformational changes that 
occur in G when exposed to a pH below 6.3.  Therefore, this assay is used as a tool to 
identify if the mutations made to the G protein interfere with the ability to undergo the 
pH triggered conformational changes.  To determine if the mutations made in the 
membrane-proximal region of G affected pH dependent conformational changes, cells 
expressing either wild type or a mutant G protein were lysed in a detergent solution 
buffered to pH 5.2, 6.1, or 7.4 and treated with TPCK-trypsin for 30 minutes at 37°C.  
The reaction was stopped by the addition of aprotonin and lysates were 
immunoprecipitated using a polyclonal α-VSV antibody and then analyzed on a 10%  
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Figure 3-4.  Cell-cell fusion in transiently transfected cells.  BHK-21 cells were 
transiently transfected with varying amounts of plasmid encoding the mutant proteins to 
set the expression levels greater than or equal to wild type.  Approximately 20 hours post 
transfection, the cells were treated in media buffered to pH 7.0, 6.0, 5.5, or 5.2 and 
images were collected using a Zeiss Axiophot camera and Axiophot software.  Arrows 
indicate syncytium formation.   
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Figure 3-5.  Quantitation of cell-cell fusion.  (A) Quantitation of the experiment 
described in figure 3-4 was done by counting the number of unfused cells in three 
separate fields of view per condition and averaging the results.  The number of unfused 
cells was then subtracted from the total average number of cells in wells treated at neutral 
pH to obtain the number of cells fused.  Percentage of fused cells was then determined by 
dividing the number of fused cells in the low pH wells by the number of cells in the wells 
treated with fusion media buffered to pH 7.0. (B) Cells from a separate well were 
transfected at the same time as those used for the fusion assay and used for flow 
cytometry to measure surface expression. 
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SDS PAGE gel.  All of the mutants examined became sensitive to trypsin digestion at 
similar pH values as wild type indicating that the mutations do not interfere with the 
ability of the glycoprotein to undergo acid induced conformational changes required for  
fusion (Fig 3-6).  The next step in characterizing the effects of the mutations on the G 
proteins is examination of virus infectivity. 
 
 
Recovery of Recombinant Mutant VSV.   Reverse genetics was employed to recover 
recombinant VSV encoding the mutant G proteins to assess the impact that these 
mutations have on the ability of the virus to grow and spread.  All viruses were recovered 
using G complementation to compensate for any potential fusion defects and to help in 
the successful recovery of recombinant virus.  H423A/P424A/H425A was the only virus 
that was unable to be recovered after multiple attempts, despite complementation with 
wild type G.  This mutant was expressed at significantly lower levels than wild type and 
therefore could not be examined in terms of fusion.  In contrast, all the other mutants 
were recovered on the first or second attempt.  ΔH423/P424/H425 was completely fusion 
defective in the initial fusion assays using transient transfections and was able to be 
recovered using G complementation, and as expected, produced viral particles that were 
not infectious (data not shown).  Recovery of recombinant VSV encoding 
ΔH423/P424/H425 was detected by staining the cells with α-N monoclonal antibody 
(10G4) as well as observation of VSV induced cytopathic effects. After recovery of wild 
type G complemented recombinant virus encoding ΔH423/P424/H425, the recovery 
supernantant was used to infect cells to produce virus expressing the mutated G protein 
on the virion surface.  Subsequent infection of fresh cells with the ΔH423/P424/H425 
resulted in no cytopathic effects, indicating the virus was not infectious.  The recovered 
recombinant viruses containing the mutated G proteins were then characterized based on 
their growth kinetics, surface expression, and fusion capacity. 
 
 
One-Step Growth Curve.  To determine the growth kinetics of the viruses encoding the 
mutated G proteins, a one-step growth curve was performed. The cells were infected with 
mutant and wild type virus (that had been titered in duplicate) at an MOI of 0.1 pfu and 
rinsed three times after the infection, before replacing the inoculum with fresh media to 
help ensure the initial infection was the same for all viruses.  Interestingly, titers for 
rVSV-H425A, rVSV-D435A/D436A/E437A and rVSV-T444A/G445A initially were 
lower than that of Wt, but by 4 hrs post infection reached wild type levels (Fig 3-7A).  
Surprisingly, D435A/D436A/E43A, which appeared to have a decrease in the pH 
threshold for fusion (Fig 3-3, Fig 3-4), was able to grow to near wild type titers 
suggesting efficient fusion activity (entry).  Likewise, rVSV-H425A, T444A/G445A, and 
N449A/P450A all grew to wild type titers, as expected based on the cell-cell fusion and 
surface expression phenotypes observed (Fig 3-2 and 3-5).   
 
The recombinant viruses all reached wild type titers by 4 hours post infection and 
maintained near wild type levels through 16 hours (Fig 3-7A).  At 16 hours post infection 
the supernatants were harvested, virus was pelleted by centrifugation through a 20% 
sucrose cushion and an aliquot was analyzed for protein content by SDS-PAGE.  As was  
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Figure 3-6.  pH dependent protease sensitivity.  BHK-21 cells were transfected with 
the appropriate plasmid DNA, metabolically labeled with 35S-methionine, lysed with 
detergent (TX-100) buffered to the indicated pH (7.4, 6.1, or 5.2), treated or not treated 
with trypsin-TPCK, and then immunoprecipitated using a polyclonal α-VSV antibody 
and analyzed by SDS-PAGE 
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Figure 3-7.  One-step growth curve measuring virus infectivity.  (A) BHK-21 cells 
were infected at an MOI = 10 for 1 hour.  The cells were washed two times to remove 
any unbound virus and the supernatants were collected over 16 hours and used in a 
standard plaque assay to determine the titer at various times post infection. (B) The titers 
at 16 hours from three individual experiments were averaged and expressed PFU/ml.  (C) 
Virus purified from the supernatant of the infections in (B) were analyzed by SDS-PAGE 
and the gel was stained with Coomassie to visualize viral proteins released from cells 
after 16 hours. 
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expected based on the one-step growth curve, similar amounts of virus were released 
compared to wild type and the amount of G protein incorporated appeared to be similar to 
wild type virus (Fig 3-7B and 3-7C). 
 
To further assess the replication capacity of viruses encoding the mutated G 
proteins, plaque sizes from a standard plaque assay were examined by staining with the 
monoclonal antibody, I1, which is directed to G.  All of the plaque sizes were comparable 
to those of wild type VSV, with only the T44A/G445A mutant being slightly reduced 
(Fig 3-8).  These data confirm what was seen in the one-step growth curve, indicating 
that the mutations did not affect the growth or spread of the virus at late time points post 
infection.  Since the recombinant VSV encoding the G protein with the T444A/G445A 
mutation reached wild type titers the reduced plaque does not likely indicate a growth 
defect.  Interestingly, the plaque assay further confirmed the results seen in the standard 
growth curve indicating the D435A/D436A/E437A mutant grew and spread like wild 
type.  These results were surprising based on the decrease in pH required to trigger cell-
cell fusion in transiently transfected cells. 
 
 
Surface Expression and Fusion in Virally Infected Cells.   A previous report showed 
that some viruses encoding G proteins with minimal fusion capacity in transient 
transfection assays can still be infectious in the context of virus infection (Cross, Wharton 
et al. 2001; Jeetendra, Ghosh et al. 2003).  These results were explained by suggesting 
that a small fusion pore is able to form, allowing for transfer of the nucleocapsid into the 
cell but not large enough for polykaryon formation. To examine this possibility, cells 
were infected with the rVSV mutants, and cell surface expression was measured by flow 
cytometry at 6 hours post infection using a monoclonal G antibody (Fig 3-9).  Surface 
expression of the mutated G proteins was similar to that of wild type.  Also, a fusion 
assay was conducted at the same time point post infection (6 hours) in which the cells 
were treated with fusion media buffered to pH 6.1, or 5.8.  As expected the H425A 
mutant and the N449A/P450A mutant showed wild type or greater fusion levels (Fig 3-
10).  Unexpectedly, the D435A/D436A/E437A mutant also fused like wild type in the 
viral cell-cell fusion assay.   
 
 
Presence of Cleaved G on the Recombinant VSV Virion.  Since the phenotypes of the 
D435A/D436A/E437A mutant in experiments involving transiently transfected cells did 
not correlate with those observed in the context of virus infected cells, I wanted to 
examine the amount of cleaved G on the virion surface.  VSV has been shown to have a 
population of G on its virion surface that has been cleaved, leaving the membrane 
proximal domain, transmembrane domain, and cytoplasmic tail (GS).  Experiments have 
indicated that this truncated G protein can potentiate the activity of fusion proteins that 
either are defective or do not fuse on their own (Robison and Whitt 2000; Jeetendra, 
Robison et al. 2002).  Based on these findings, I hypothesized that the difference 
observed in the transient plasmid-expressed cell-cell fusion assays and the virus 
infectivity/virus infected cell-cell fusion assay may be due to an enhanced cleavage of 
D435A/D436A/E437A and the higher level of GS may help to overcome the defects in  
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Figure 3-8. Plaques of wt and mutant VSV.  (A) Standard plaque assay was performed 
followed by staining the cells with a G specific monoclonal antibody, I1. Plaques labeled 
rVSV-wt represent the wild type plaques observed in the same experiment as the panels 
to the right of the control (B) Relative plaque sizes were determined by photographing 
plaques using a Zeiss axiophot camera and Axiovision software, enlarging the 
photographs and measuring the diameter horizontally and vertically.  The diameters were 
averaged and used to calculate the relative area of the plaques.  The data represent the 
average measurements from three separate plaques expressed as a percentage of wild 
type. 
46 
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Figure 3-9. Surface expression in virally infected cells.  BHK-21 cells were infected at 
an MOI=10 at 31°C.  After 1 hr the media was replaced with fresh DMEM containing 5% 
FBS and the cells were transferred to 37°C.  6 hrs post infection the cells were fixed and 
processed for flow cytometry using a G monoclonal antibody, I1 followed by a secondary 
antibody conjugated to FITC.  Relative surface expression was calculated as described in 
Fig 3-2. 
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Figure 3-10.  Cell-cell fusion in virally infected cells.  BHK-21 cells were infected with 
the indicated virus as described in figure 3-9.  At 6 hours post infection, the cells were 
treated with fusion media buffered to pH 7.0, 6.1, or 5.8 for 1 minute at room 
temperature.  The fusion buffer was replaced with DMEM plus 5% FBS and the cells 
were incubated at 37°C for 30 minutes.  Cell-cell fusion was quantitated by counting cells 
in three separate fields of view and subtracting from the total cell number.  Relative 
fusion index was then calculated by dividing the number of fused cells from the number 
of unfused cells at pH 7.0. 
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fusion activity.  To examine this possibility, purified virus was immunoblotted using an 
antibody that binds to the cytoplasmic tail (C-tail) of G.  As shown in figure 3-11 there 
was more GS detected in the cells infected with the recombinant VSV encoding the G 
protein containing the D435A/D436A/E437A mutation.  The rest of the viruses 
containing mutated G proteins appeared to have similar amounts of GS as was seen with 
wild type (data not shown). 
 
 
Discussion 
 
 Determination of crystal structures from VSV G (Roche, Bressanelli et al. 2006; 
Roche, Rey et al. 2007) and herpes simplex virus gB (Heldwein, Lou et al. 2006) led to 
classification of a new group of fusion proteins, the class III proteins, as previously 
mentioned.  More recently, the structures of the baculovirus gp64 (Kadlec, Loureiro et al. 
2008), and the Epstein-Barr virus gB (Backovic, Longnecker et al. 2009) fusion proteins 
were solved, revealing structural homology to the herpes gB and VSV G fusion proteins,  
further supporting the need for a third classification.  VSV G is the only class III fusion 
protein in which both pre- and postfusion structures have been solved.  Availability of the 
structures provides a wealth of information in regard to the structural transitions that take 
place when the protein is exposed to low pH in the endosome during viral entry.  
However, G protein was cleaved upstream of the membrane-proximal region for 
successful crystallization, therefore, no structural information exists for this region.  
Likewise, crystal structures of other fusion proteins have had the same limitation, 
resulting in the absence of structural data to help understand the contribution of these 
regions to the fusion event.   
 
We chose to employ a mutational analysis approach in an effort to determine if 
individual residues within the membrane proximal region of VSV G are needed for 
membrane fusion.  Previous mutational analyses of G in which large deletions or 
insertions were made suggested a role for this region in the membrane fusion process 
(Jeetendra, Ghosh et al. 2003).  The large insertions and deletions indicated the size of 
this region may be important to G mediated membrane fusion, however did not determine 
if individual residues may be critical.  Sequence alignment of a number of closely related 
Vesiculoviruses revealed a high level of conservation of the residues in this region 
(Robison and Whitt 2000) (Fig 3-1). The crystal structure in the post fusion conformation 
extends to the H407.  H407 correlates with the histidine at position 423 that is described 
in this chapter.  The numbering differs between the crystal structure and the work 
presented here is because the crystal structure numbering represents the G protein with 
the signal sequence cleaved (16 residues) and the numbering of residues in this chapter 
includes the signal sequence.  H407 (H423) is shown to participate in a salt bridge with 
an aspartate in the post fusion conformation (D137 in crystal structure).   Based on the 
crystal structures, the authors conclude that the pH dependent conformational changes are 
driven by the protonation of specific histidine residues.  The direct role of histidines in 
pH dependent conformational changes required for fusion was earlier hypothesized based 
on chemical modification of various histidine residues in G protein, resulting in  
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Figure 3-11.  Presence of cleaved G protein on the virion.  BHK-21 cells were infected 
with either wild type VSV or rVSV-D435A/D436A/E437A at an MOI=10 for 16 hours 
then supernatants were analyzed by SDS-PAGE and either treated with Coomassie to 
visualize amount of virus or immunoblotted using a polyclonal G antibody specific to the 
C-tail. 
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abolished fusion activity of VSV G (Carneiro, Stauffer et al. 2003).  Furthermore, when 
the chemical modification was reversed, cell-cell fusion capacity was restored.  As 
mentioned previously, VSV G is unique in that the conformational changes that occur 
when exposed to acidic pH are completely reversible (Roche and Gaudin 2002).  Another 
interesting feature of this fusion protein is the constant association and dissociation of G 
trimers (Lyles, Varela et al. 1990; Zagouras, Ruusala et al. 1991; Zagouras and Rose 
1993).  Due to these characteristics, G may require specific interactions to stabilize the 
states needed for the fusion event.  The structural data for G suggests that in the prefusion 
conformation, the fusion domain and the membrane proximal region interact to stabilize 
the structure.  Exposure to low pH interrupts these interactions, releasing the fusion 
peptide and propelling it toward the target membrane.  The final conformational changes 
involve the formation of salt bridges between acidic residues and protonated histidines to 
help lock G in the postfusion structure that pulls the two membranes together to allow for 
membrane fusion (Roche, Bressanelli et al. 2006; Roche, Rey et al. 2007). 
 
The first step in characterization of these mutant G proteins was to assess their 
expression levels.  H425A, D435A/D436A/E437A, T445A/G446A, and N449A/P450A 
were all expressed on the cell surface at levels similar to that of wild type.  Both the TG 
motif and the NP motif are completely conserved among the Vesiculoviruses aligned (Fig 
3-1), however, it appears these residues are not conserved for their role in proper folding 
of the protein.  ΔHPH, H423A/P424A/H425A, ΔH425, F440A/F441A were all expressed 
at levels greatly reduced from that of wild type. These findings suggest that the HPH and 
FF motifs have critical roles in the proper folding of G for localization to the cell 
membrane.  To examine further the folding of these proteins and the movement through 
the secretory pathway, an Endo H analysis was employed.  Wild type G is typically 
transported to the trans-Golgi apparatus with a half time of 18-20 minutes (Doms, Keller 
et al. 1987; Balch 1989; Machamer, Doms et al. 1990).  The results from the endo H 
analysis revealed the ΔH423/P424/H425 mutant was slower in transport kinetics as 
compared to wild type G, as was expected based on the reduced expression levels.  
Interestingly, the ΔH425 and F440A/F441A mutants appeared to acquire resistance to 
Endo H digestion at around the same time point as wild type G (~ 30 minutes) and by 60 
minutes were completely resistant to Endo H digestion, indicating the protein should be 
expressed on the cell surface at levels similar to wild type G.  Expression levels for the 
ΔH425 mutant were observed to be reduced by ~80% as compared to wild type G 
protein, however, the lower level of surface expression did not appear to be due to 
inefficient transport to the cell surface.  Surface expression levels were determined by 
flow cytometry, using a G specific monoclonal antibody (I1) for detection while in the 
Endo H assay, G was immunoprecipitated using a polyclonal anti-VSV antibody.  One 
possible explanation for the disconnect in surface expression levels and the kinetics of 
transport observed for these mutant G proteins is that the I1 antibody epitope becomes 
partially hidden with a slight misfold in the protein.  Less efficient binding of the I1 
antibody would cause the data to indicate the expression levels were reduced.  However, 
the Endo H resistance would not be affected because this experiment uses a polyclonal 
anti-VSV antibody.  To address this possibility, surface expression should also be 
examined in a biotinylation assay.  The kinetics of transport are reduced as compared to 
wild type for the HPH deletion mutant and H423A/P424A/H425A mutant, while the 
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ΔH425 and F440A/F441 mutants acquire resistance to Endo H digestion by 30 minutes as 
is seen with wild type. Both the ΔH423/P424/H425 and H423A/P424A/H425A mutants 
are more reduced in surface expression than is seen in the ΔH425 and F440A/F441A 
mutants.  Perhaps, these mutants are able to stabilize the prefusion form slightly better 
than those with the HPH motif deleted or mutated.  The pH in the secretory pathway 
plays a pivotal role in the efficient posttranslational modifications and processing of 
proteins (Carnell and Moore 1994).  As the proteins progress along this pathway the pH 
decreases.  In the endoplasmic reticulum the pH is neutral (~7.2) (Kim, Johannes et al. 
1998; Wu, Grabe et al. 2001).  The cis-Golgi has a pH of around 6.7 (Kim, Lingwood et 
al. 1996) and the pH decreases to around 6.0 in the trans-Golgi (Seksek, Biwersi et al. 
1996; Demaurex, Furuya et al. 1998).  Perhaps, if the mutations made to the MPR of the 
G protein affected pH dependent conformational changes the transport to the cell surface 
was also affected because the proteins could be in a different conformation than the wild 
type G proteins as they progress through the increasingly acidic environment within the 
secretory pathway.   
 
The next step in characterizing the role of the membrane proximal residues in G 
was to assess the affects the mutations had on the protein function.  Cells transiently 
expressing either the wild type or mutated proteins were treated with fusion media.  The 
fusion media was buffered to pH 7.0, 6.0, 5.5, or 5.2.  At pH 7.0 the majority of wild type 
G protein should be in prefusion conformation and therefore minimal fusion should be 
observed.  When the cells expressing the G proteins are treated with fusion media at pH 
6.0, extensive cell-cell fusion should be observed in wild type, since the threshold pH for 
fusion is around 6.2-6.3.  If fusion is observed at this pH one would expect to see fusion 
with in the mildly acidic environment of the early endosomes as is observed in wild type 
G mediated membrane fusion.  Treatment with media at pH 5.5 as well as 5.2 represents 
the acidic environment found in the late endosomes.  An initial screen to identify mutated 
G proteins with fusion defects revealed those with mutations to the HPH, FF, and DDE 
motif were fusion defective at pH 6.0.  Interestingly, ΔH423/P424/H425 was completely 
fusion defective, even at pH 5.2 while mutations to the DDE and FF motifs resulted in a 
reduced pH threshold for fusion.  VSV G typically is believed to mediate fusion in the 
early endosomes where there is a mildly acidic environment that correlates with the 
threshold pH required for fusion which is 6.2-6.3.  Since the experiment was not done 
with smaller increments (0.1 pH units) it remains to be seen at exactly what pH fusion is 
occurring and therefore, it is not known at exactly what point in the endocytic pathway 
the RNP is released for these mutated G proteins.  However, if fusion is not seen until the 
pH reaches 5.5 (Fig 3-4, 3-5) one would expect the viral RNP to be released in to the host 
cell cytosol from the late endosomes or lysosomes as opposed to the early endosomes.   
 
We hypothesized that the mutated residues in G that caused a reduced capacity for 
fusion are likely involved in the structural transitions between the pre- and postfusion 
conformations.  Therefore, we examined the ability of the G protein to acquire trypsin 
resistance when exposed to low pH.  The experiment revealed that all of the proteins that 
were defective in fusion or required a lower pH for fusion were able to undergo pH 
dependent conformational changes (as observed for wild type) making them resistant to 
trypsin digestion (Fig 3-6).  From these results I concluded that the mutations affected a 
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step in the fusion process after the proteins underwent the low pH triggered 
conformational changes.  This step is possibly the stabilization of the postfusion 
conformation.  Therefore, the mutated G proteins are able to undergo conformational 
changes required for fusion but may not maintain this structure long enough to pull the 
two membranes together for membrane merger and pore formation.   
 
Experiments using recombinant virus expressing the mutated G proteins revealed 
an interesting disconnect in data.  Mutation of the DDE motif resulted in a reduced pH 
threshold for fusion in cells transiently expressing the protein.  Previous studies in our lab 
identified mutants with a reduced pH threshold for fusion that also showed a reduction in 
titer as well as plaque size (Fredericksen and Whitt 1998).  Based on these previous 
findings we expected that those viruses expressing the mutated G proteins with a 
decreased threshold pH for fusion would grow to lower titers and produce smaller 
plaques as compared to wild type G.  Recombinant VSV encoding 
D435A/D436A/E437A was recovered and a one-step growth curve was performed.  
Surprisingly, the data from this experiment indicated the virus was able to grow and 
spread as well as wild type VSV.  The growth curve also revealed another interesting 
feature.  The titers for H425A, D435A/D436A/D437A, T444A/G445A were all over a 
log reduced from that of wild type at the two hour time point but by about 7 hours had 
reached wild type levels.  These data indicate the cells were not initially producing as 
much virus but between the 2 and 7 hour time points, produced much more virus.  The 
viruses with the reduced growth phenotype at two hours possibly are replicating and 
making more progeny virus, however the virus is unable to bud through the host cell 
plasma membrane to be released.  After 2 hours this block is apparently relieved and the 
progeny virus that had accumulated in the cell could be released, explaining the steep 
increase from the 2 to 7 hour time points. Further experiments would need to be done to 
identify the exact step affected by the mutations.   
 
The next step in characterizing the recombinant viruses expressing the mutated G 
proteins was to look at the plaque formation.  Once again, we were surprised to see the 
DDE mutant formed near wild type size plaques.  Interestingly the T444A/G445A 
mutant’s plaque size was reduced from that of wild type.  This mutant was expressed on 
the cell surface, had no fusion defect, and grew to wild type titers at 16 hours post 
infection.  To further examine the fusion activity of the mutated G proteins, surface 
expression and fusion capacity was measured in virally infected cells.  Data from all of 
the viral infections correlated with what was observed in the experiments in which cells 
were transiently transfected with the exception of the D435A/D436A/E437A mutant.  
This mutant appeared to have a very different phenotype when transfected into cells 
versus when cells were infected with virus encoding the mutated G protein.  I 
hypothesized that G protein was possibly being cleaved, producing more G-stem 
(truncated G protein containing C-terminus, transmembrane domain, and a short 
ectodomain) on the virion surface. 
 
Previous studies in our lab have shown that the truncated G protein, GS, can 
potentiate the membrane fusion of glycoproteins that do not normally mediate fusion on 
their own.  Furthermore, use of a three color fusion assay showed that GS can induce 
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lipid mixing when expressed alone, but cannot proceed to full fusion (Jeetendra, Robison 
et al. 2002).  Since GS is present on the wild type VSV virion at low levels, we 
hypothesized that the mutation may have caused a reduction in cell-cell fusion that the 
virus was able to compensate for in the context of infection by producing more GS on the 
virion surface.   
 
Based on the hypothesis that acidic residues may form interactions to stabilize G 
in the postfusion conformation, we expected to see a reduction or defect in fusion 
capacity of the D435A/D436A/E437A mutant.  In the context of transient transfections, 
we saw a reduction in fusion, however when the recombinant virus was recovered it grew 
to wild type levels.  GS was detected at seemingly higher levels in the rVSV-
D435A/D436A/E437A virus in comparison to that of wild type rVSV (Fig 3-11).  Efforts 
to visualize GS levels in cells transfected with the mutant glycoprotein were unsuccessful 
(data not shown)  so we can only suggest possible roles the added GS plays since we are 
uncertain if there is a population of GS present on the surface of cells transiently 
expressing D435A/D436A/E437A.  The role of GS during VSV infection has yet to be 
understood.  To our knowledge this is the first suggestion that GS has a direct role in 
efficient entry of the virus.  
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Chapter 4:  Examination of Variants with Enhanced Growth Phenotypes 
 
 
Introduction 
 
A hallmark feature of RNA viruses is the very high rate of mutations that arise 
during replication.  These high mutation rates can be attributed to the error prone RNA 
dependent RNA polymerase that is used for replication (Steinhauer, De La Torre et al. 
1989; Bilsel and Nichol 1990; Kearney, Donson et al. 1993).  RNA viruses make up the 
largest group of pathogens affecting humans, animals, and plants. Many riboviruses cause 
severe disease in humans, some of these include; Influenza virus, HIV-1, and Ebola virus.  
High rates of mutation are believed to be an asset to the viruses as they are better able to 
adapt to changing environments and become more fit for infection.   
 
Vesicular stomatits virus has been used as a model for evolutionary virology due 
to its broad tropism, simple genetic organization, and ability to be grown to high titers in 
cell culture.  VSV enters the host cell through receptor mediated endocytosis that is 
dependent upon G protein binding to the host cell (Matlin, Reggio et al. 1982).  Once the 
pH drops in the endosome, G protein undergoes a reversible conformational change 
allowing for the bipartite fusion loop to insert into the endosomal membrane (Roche, 
Bressanelli et al. 2006; Roche, Rey et al. 2007).  Further conformational changes result in 
the two opposing membranes being pulled together causing the initial membrane merger 
event (hemifusion), stalk formation, and finally formation of a fusion pore in which the 
viral nucleocapsid can pass through and be released into the host cell cytoplasm.  VSV 
replication occurs once the virus has been released into the host cell cytoplasm.  Since 
VSV does not undergo homologous recombination during replication any base changes 
that arise during replication occur due to misincorporation of ribonucleoside 
triphosphates because of the error prone RNA dependent polymerase and the lack of 
proofreading (Drake 1999; Drake and Holland 1999). 
 
Chapter 3 focused solely on identifying residues within the G protein membrane-
proximal region of VSV that are important for membrane fusion.  Mutations made to 
H425 (ΔH425) and F440/F441, within this region, resulted in recombinant viruses that 
rapidly acquired second site mutations or changes from the intended mutation.   Studies 
in this chapter were aimed at characterizing the new mutants that arose from passaging 
the viruses.  Two variants were observed in the recovery supernantants from the 
recombinant virus encoding ΔH425.  The variants were; ΔH425/I426S/S438I and 
ΔH425/S438I.  The recovery supernatants from recombinant virus encoding 
F440A/F441A were observed to contain more variants, including; F440V/F441A, 
F440T/F440A, F440A/F441A/S438I, and F440A/F440A/CT9 (F440A/F440A/CT9 has a 
cytoplasmic tail that is truncated to only 9 residues).  Experiments conducted, in chapter 
3, using transient transfections resulted in a decreased level of surface expression and a 
reduced pH threshold for fusion for the ΔH425 and F440A/F441A mutants (fusion was 
observed at pH 5.5 but not 6.0).  Therefore the work presented in this chapter 
characterizes the variants that arose during passage to identify further residues that may 
play a role in the efficient entry and spread of VSV.   
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Results 
 
 
Identification of Rapidly Acquired Mutations.  In chapter 3, G proteins with ΔH423 or 
F440A/F441A mutations revealed interesting fusion phenotypes in that a reduction in the 
pH threshold for fusion was observed.  Reverse genetics with G-complementation was 
used to recover recombinant VSV encoding G proteins containing these mutations.  Since 
the cell-cell fusion assays indicated these viruses may have a reduced capacity to enter 
cells due the shift in the pH threshold required for membrane fusion activity, the 
recombinant viruses were generated using G complementation to help ensure a successful 
recovery.  Passage on cells not expressing wild type G protein then should produce VSV 
with only the desired mutant G protein embedded in the envelope.  In chapter 3, when the 
plasmids encoding the mutated G proteins were transfected into cells and treated with 
fusion media buffered to various pH values, fusion was not observed at pH 6.0 but was 
seen at pH 5.5 and pH 5.2.  As expected, fusion activity was observed in cells expressing 
wild type G at pH 6.0.  Since fusion was observed in the transiently transfected cells we 
expected to recover virus that was infectious, but that perhaps would grow to lower titers 
than wild type G.  Prior studies have shown mutations in G that caused a reduction in the 
pH required to induce membrane fusion resulted in virus that grew to lower titers than 
wild type VSV (Fredericksen and Whitt 1998).  Once the viruses were recovered, they 
were passaged on BHK-21 cells without G complementation (using 100µl, or 5% of the 
recovery supernatant) to produce virus with the mutated G on the virion surface (P1).  
Supernatant from this infection was then titered using a standard plaque assay and then a 
single plaque was selected and resuspended in 500µl of DMEM + 5% FBS to obtain a 
plaque isolate (P2).  Supernatant from the plaque isolate (P2) was amplified by another 
passage on BHK-21 cells (using 200µl) to generate the P3 stock. Finally after a total of 3 
passages on cells without G complementation a working stock of the virus was generated 
by infecting at an MOI = 0.1 (P4).  The P4 stock of recombinant VSV encoding G with 
the ΔH425 mutation grew to a very low titer (~ 6 x 106 PFU/ml).  When growing up 
additional stocks of the virus I used the P3 working stock to generate a new working 
stock (and each successive passage after, for additional stocks), producing later passages 
of the virus.  Later stocks of the virus (P5 and P6) grew to significantly higher titers (~2 x 
107 and 2 x 109, respectively).  These findings contrast with what was observed in the 
recombinant viruses encoding mutant G proteins that displayed efficient cell-cell fusion 
activity.  For those mutants (T444A/G445A and N449A/P450A), the titers from the early 
stocks were near wild type level (~1 x 109 PFU/ml).  The plaque sizes observed from the 
initial recovery supernatant (for both ΔH425 and F440A/F441A) were also significantly 
smaller than those observed after the virus had been passaged several times (data not 
shown).  
 
To ensure the P4 working stocks of the viruses contained G proteins with only the 
desired mutations, BHK-21 cells were infected at an MOI = 1 for 6 hours using virus 
from the working stock (P4), RNA was extracted from the cells, reverse transcribed, and 
PCR amplified using a sense primer upstream of the KpnI site and a nonsense primer in 
the 3’UTR of G.  The resulting cDNA was used to sequence the G gene and surprisingly, 
revealed additional mutations that were not originally present in the plasmids used for 
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recovery.  The P4 stock of ΔH425 had acquired two additional mutations, I426S and 
S438I.  Interestingly, virus stock recovered using plasmid encoding F440A/F441A 
revealed a F440V/F441A mutation.  The original plasmids used in recovery of the 
recombinant VSVs encoding the mutated G proteins were re-sequenced confirming that 
only the original constructed mutations were present. 
 
 
Isolation of Plaques to Identify Additional Mutants.  Based on the initial observations of 
additional mutations arising in the recombinant VSV encoding the mutated G proteins, I 
decided to isolate multiple plaques from the original rVSV-ΔH425 and rVSV-
F440A/F441A recovery supernatants using a standard plaque assay.  Approximately 24 
hours post infection 10 plaques of various sizes were isolated by using a Pasteur pipette 
and being careful to only obtain one plaque at a time.  Plaques of various sizes were 
chosen in an effort to select for possible variants that grew and spread at different rates.  
As described, the plaque isolate was re-suspended in 500µl of DMEM containing 5% 
FBS.  BHK-21 cells were infected with supernatant from the plaque isolate re-suspension 
and RNA extracted from the cells. The viral RNA was reverse transcribed and PCR 
amplified using the coding primer, MW36, and the non-coding primer 3464 (Table 2-1) 
(Fig 4-1).  The entire G gene was sequenced, showing that no additional mutations arose 
outside of the membrane-proximal region.  Alignment of these sequences with those from 
wild type GIND revealed a mixed population of viruses from the original recovery 
supernatant (Fig 4-2).  The recombinant VSV that was originally cloned to express a G 
protein containing only the ΔH425 mutation yielded virus with the intended mutation, but 
there was also virus expressing G containing an additional amino acid change at position 
438 (serine to isoleucine).  None of the plaque isolates observed in this particular 
experiment contained a G protein with the double site mutation at I426 and S438 
(ΔH425/I426S/S438I).  This mutant G was only observed when the initial recovery 
supernatant had been passaged 4 times in the production of working viral stocks.  Since 
this mutant was observed in the working stocks that had been passaged more times than 
the plaque isolates the additional I426S mutation likely arose in passaging multiple times 
and this mutant will be included in the studies.    
 
When 10 plaque isolates were sequenced from the recovery supernatant of rVSV-
F440A/F441A, a larger number of variants were observed.  The mutations that arose 
included; F440V/F441A, F440T/F441A, F440A/F441A/S438I, and F440A/F441A/CT9 
(F440A/F441A/CT9 acquired a stop codon in the C-tail that resulted in a tail with only 9 
residues).  Interestingly none of the plaque isolates contained G proteins with the original 
intended mutation, F440A/F441A, that was present in the plasmid used for recovery of 
the virus.  
 
 
Standard Plaque Assay.  One means by which to assess the ability of a mutated virus to 
grow and spread efficiently is through the use of a standard plaque assay.  Figure 4-3 
shows representative plaques for each of the mutant viruses that are stained with the G  
58 
Figure 4-1.  Selection of plaque isolates.  Initial recovery supernatants from viruses 
encoding ΔH425 and F440A/F441A were titered using a standard plaque assay.  24 hrs 
post infection, plaques of various sizes were picked and resuspended in 0.5ml DMEM 
containing 5% FBS.  Virus in 0.2ml of the eluted plaque isolate was used to infect ~ 5 x 
105 BHK cells and  RNA was extracted from cells at 6 hours post infection, reverse 
transcribed, and PCR amplified .  The resulting cDNA was then sequenced (University of 
Tennessee Health Science Center Molecular Resource Center).  Alternately, an aliquot of 
the eluted plaque isolate was titered on BHK-21 cells and used to infect a 10 cm plate at 
an MOI = 0.1 to grow up a working stock.  RNA was extracted from the cells used to 
grow up the working stock, reverse transcribed, and PCR amplified. 
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Figure 4-2.  Sequence alignments of plaque isolates.  Unpassaged supernatants from a 
recovery of rVSV encoding G containing ΔH425 and F440A/F441A, respectively, were 
titered using a standard plaque assay.  Approximately 24 hrs post infection 10 plaques 
from each plaque assay were removed using a Pasteur pipette, resuspended in DMEM 
containing 5% FBS and the eluted virus (plaque isolate) was used to infect BHK cells.  
RNA was extracted from the cells, reverse transcribed, the membrane-proximal region, 
transmembrane, and cytoplasmic tail were PCR amplified and the resulting cDNA was 
used for sequencing 
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FEHP-IQDAASQLPDDEILFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIETranslat ion of DeltaH425 plaque 1 (80)
FEHP-IQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIETranslat ion of DeltaH425 plaque 2 (80)
FEHP-IQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIETranslat ion of DeltaH425 plaque 3 (80)
FEHP-IQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIETranslat ion of DeltaH425 plaque 4 (80)
FEHP-IQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIETranslat ion of DeltaH425 plaque 5 (80)
FEHP-IQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIETranslat ion of DeltaH425 plaque 6 (80)
FEHP-IQDAASQLPDDEILFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIETranslat ion of DeltaH425 plaque 7 (80)
FEHP-IQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIETranslat ion of DeltaH425 plaque 8 (80)
FEHP-IQDAASQLPDDEILFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIETranslat ion of DeltaH425 plaque 9 (80)
FEHP-IQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIETranslat ion of DeltaH425 plaque 10 (80)
FEHPHIQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIETranslat ion of Wt G (376)
376 458390 400 410 420 430 440(376)
FEHPHIQDAASQLPDDESLVAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDTranslat ion of F440A/F441A plaque 1 (80)
FEHPHIQDAASQLPDDEILAAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDTranslat ion of F440A/F441A plaque 2 (80)
FEHPHIQDAASQLPDDEILAAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDTranslat ion of F440A/F441A plaque 3 (80)
FEHPHIQDAASQLPDDEILAAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDTranslat ion of F440A/F441A plaque 4 (80)
FEHPHIQDAASQLPDDEILAAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDTranslat ion of F440A/F441A plaque 5 (80)
FEHPHIQDAASQLPDDESLTAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDTranslat ion of F440A/F441A plaque 6 (80)
FEHPHIQDAASQLPDDESLAAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIK-KHTKKRQIYTDTranslat ion of F440A/F441A plaque 7 (80)
FEHPHIQDAASQLPDDEILAAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDTranslat ion of F440A/F441A plaque 8 (80)
FEHPHIQDAASQLPDDEILAAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDTranslat ion of F440A/F441A plaque 9 (80)
FEHPHIQDAASQLPDDEXLVAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDTranslat ion of F440A/F441A plaque 10 (80)
FEHPHIQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDTranslat ion of Wt G (376)
61 
 
 
 
Figure 4-3.  Plaque sizes.  Representative plaques are shown from plaque assays in 
which the cells were infected with viruses containing G mutations as indicated.  Three 
separate experiments were done with wild type controls from each experiment shown.  
Approximately 36 hrs post infection plaques were stained with I1 monoclonal antibody 
followed by a fluorescently conjugated secondary antibody. 
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specific monoclonal antibody, I1, followed by a fluorescently conjugated secondary 
antibody.  Three panels showing wild type VSV plaques are shown.  Three separate 
experiments were done so the three wild type panels the positive control for each 
experiment.  The sizes of the wild type plaques vary in part due to the confluency of the 
cells that are infected.  If a plate is less confluent, a larger plaque would likely be 
observed whereas when the cells are highly confluent and touching one another the 
plaques generally appear smaller.  Similar amounts of cells were used each of the plates 
for an experiment (but may vary between experiments).  The plaque sizes of the 
F440T/F441A, F440A/F441A/CT9, F440V/F441A, and ΔH425 mutant virus infections 
were greatly reduced in size from the wild type control.  Interestingly, F440A/F441A/ 
S438I, ΔH425/I426S/S438I, and ΔH425/S438I plaques were all near the same size as 
wild type plaques.  Since the mutations arose upon passaging the virus very few times we 
could not be sure that during these experiments further mutations were not arising.  
Therefore, the rest of the characterization of these mutants will be done using cells 
transiently expressing the protein instead of virus infection. 
 
 
Surface Expression in Transiently Transfected Cells.   The first step in identification of 
possible advantages variants may have gained, enabling outgrowth of the mutant parent 
virus, was to examine the surface expression of these mutant G proteins using transient 
transfection assays.  First, the mutant G proteins were sub-cloned into pCAAGS-GIND 
expression vectors.  This was done by extracting viral RNA from infected cells, reverse 
transcription, and then the region containing the mutations was amplified using MW36 
and 3464 (as previously described).  The amplicon was digested with KpnI and NheI 
restriction enzymes and subcloned into a pCAGGS-GIND plasmid digested with the same 
enzymes.  The plasmids were sequenced to ensure no unexpected mutations arose during 
PCR amplification.   
 
Since the original constructed mutations resulted in a reduced level of surface 
expression (Fig 3-2), I wanted to determine if the additional mutations arose to 
compensate for the reduced cell surface expression.  All of the mutants were expressed as 
well or better than wild type GIND with the exception of the F440A/F441A/CT9 mutant, 
which was expressed less than 20% that of wild type (Fig 4-4).  This result was not 
surprising since previous studies with a mutant G protein containing only 9 residues in 
the C-tail showed cell surface expression levels approximately 38% that of wild type G 
(Whitt et al 1989).  These results indicated that the additional mutations that arose, with 
the exception of F440A/F441A/CT9, enhanced surface expression of the mutated G 
proteins.   
 
 
Cell-Cell Fusion in Transiently Transfected Cells.  The next step in potentially 
understanding the means by which the mutations acquired during passaging of the virus 
overcame growth defects was to examine cell-cell fusion capacity.  A syncytium 
formation assay was used to compare the cell-cell fusion activity of the mutants with that 
of wild type G.  Since the cell-cell fusion assays in BHK-21 cells transiently expressing 
G proteins containing F440A/F441A and ΔH425 mutations indicated the threshold pH for  
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Figure 4-4.  Surface expression in transiently transfected cells.  Surface expression 
was measured by flow cytometry of cells transiently transfected with plasmids encoding 
the appropriate G mutant. Cells were fixed approximately 24 hours post transfection and 
stained using I1 G monoclonal antibody and a secondary antibody conjugated to FITC. 
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fusion was reduced to below 6.0, I wanted to see if the additional mutations were able to 
overcome this shift.  To ensure that the mutated G proteins were expressed at levels 
greater than or equal to that of wild type G protein, I transfected cells using less plasmid 
cDNA encoding wild type than the mutant G proteins (2/5 the amount of Wt G as mutant 
G cDNA).   The F440A/F441A/CT9 mutant was still greatly reduced as compared to wild 
type G.  Unexpectedly, the ΔH425/S438I mutant was also expressed only about 50% that 
of wild type.  However, regardless of the reduced level of surface expression, significant 
cell-cell fusion could still be observed at pH 5.2 as well as pH 6.0 (Fig 4-5 and 4-6A).  
F440V/F441A and F440T/F441A both showed no cell-cell fusion at pH 6.0, but when 
treated at pH 5.2, a high level of fusion was then observed.  Interestingly, the ΔH425 
mutants initially showed a decrease in the pH threshold for fusion, but when ΔH425 
acquired the S438I mutation or both S438I and I426S mutations, fusion was induced at 
pH 6.0 (Fig 4-5 and 4-6A).  These data suggest the S438I mutation helps to overcome the 
requirement for a lower pH for fusion that results from either the ΔH425 or 
F441A/F441A mutations.  
 
 
Discussion 
 
Vesicular stomatitis virus has widely been used to study viral evolution due to the 
rapid rate at which the virus acquires mutations during replication.  RNA viruses have a 
very high mutation rate that is attributed to the error prone RNA dependent RNA 
polymerase.  The mutation rates in RNA viruses have been found to be one mutation per 
genome per round of replication (Drake 1999).   Since mutations are constantly arising, 
RNA virus populations are very heterogeneous.  This heterogeneity among the viral 
populations (in particular RNA viruses) is referred to as “quasispecies”.  A rapid rate of 
mutation among RNA viruses likely enables the viruses to become more fit for infection 
in a constantly changing environment.   
 
Studies have been aimed at determining the ability viruses to express foreign 
genes though multiple rounds of infection without mutations arising.  VSV has served as 
an attractive candidate for gene therapy and therefore examining the rate of mutation in 
this virus has proven important.  One such study identified the number of passages on 
cells in which VSV encoding CD4 could maintain CD4 expression without mutations 
arising within this gene.  Experiments indicated that VSV expressing CD4 remained 
stable for 26 passages before a mutation arose that affected expression of the foreign gene 
(Quinones-Kochs, Schnell et al. 2001).  Viruses that were more fit for infection (did not 
have the foreign gene expressed) outgrew the CD4 expressing population.  However 
when VSV expressed the measles virus F protein in addition to the G protein, the virus 
showed a loss of F protein expression after the first passage.  The authors hypothesized 
that the F protein affected some aspect of VSV growth and therefore the virus that was 
more fit for infection became predominant in the population (Schnell, Buonocore et al. 
1996; Quinones-Kochs, Schnell et al. 2001). 
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Figure 4-5.  Cell-cell fusion activity.   6 cm plates of BHK-21 cells were transfected 
using 2µg of plasmid DNA encoding wild type GIND or 6µg of plasmid DNA encoding 
each of the mutated G proteins.  2 hours post transfection the cells were trypsinized and 
plated onto 4 x 35 mm plates.  Approximately 24 hours post transfection the cells were 
rinsed one time and incubated in fusion media buffered to pH 7.0, 6.0, or 5.2 for 1 min at 
room temperature.  The media was then replaced with DMEM containing 5% FBS for 30 
minutes.  The cells were then photographed using a Zeiss Axiophot camera and Axiophot 
software. 
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Figure 4-6. Quantitation of cell-cell fusion activity.  (A) Cell-cell fusion activity was 
measured from the experiment in figure 4-5 by counting cells that had not fused in three 
separate fields of view per plate.  Percentages were calculated based on the number of 
cells fused (in three separate fields of view) as compared with plates treated at neutral pH 
(7.0) and normalized to wild type by calculating percent fusion observed.  (B) One of the 
plates from the transfection described in fig 4-5 was used to measure surface expression 
at ~ 24 hrs post transfection.  Relative surface expression as a percentage of wild type as 
described in figure 3-5 is shown. 
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Chapter 3 was aimed at understanding the role of the membrane-proximal region 
of VSV G through the use of a mutational analysis.  Two mutant viruses were recovered 
that upon passaging on BHK-21 cells began growing to significantly higher titers and 
forming larger plaques than what was seen from the original recovery supernatant.  The 
G proteins expressed on these viruses acquired additional mutations from those originally 
constructed.  Since mutations rapidly arose in these viruses I wanted to determine what 
enabled the viruses to grow and spread more readily than the original mutants (ΔH425 
and F440A/F441A).  Both ΔH425 and F440A/F441A were reduced in cell surface 
expression and had a lower pH threshold for fusion (Fig 3-2, 3-4, 3-5) and therefore, I 
hypothesized that the additional mutations enabled the virus to overcome these defects, 
allowing for more efficient growth and spread.   
 
Through the use of a standard plaque assay we were able to identify a number of 
other mutants within the recovery supernatant.  We chose to use these mutants as tools to 
attempt to understand the importance of the F440, F441, and H426 residues and possibly 
identify other residues that participate in membrane fusion or play a role in efficient 
growth and spread of the virus. The mutant viruses that we observed in the respective 
recovery supernatants were ΔH425, ΔH425/S438I (also obtained from passage P5, 
ΔH425/I426S/S438I), F440V/F441A, F440T/F441A, F440A/F441A/CT9, and 
F440A/F440A/S438I.  Interestingly, the S438I mutation was observed in both the ΔH425 
and F440A/F441A recovery supernatants indicating that mutation of this residue alone 
likely helps in overcoming the defects that cause the virus to be less infectious.  Also, 
notably, we did not identify any virus with only the F440A/F441A mutation, which may 
indicate that these two residues are very important in producing infectious virus.  
Likewise, additional mutations only arose at position F440 but not F441 possibly 
suggesting this residue is more critical to successful infection.  Experiments using cells 
transiently expressing the mutant G proteins were employed to address the role of H425, 
F440, and F441 since mutations arise so rapidly in the context of a viral infection. 
 
Further experiments in this chapter revealed that the additional mutations, with 
the exception of F440A/F441A/CT9, enhanced the cell surface expression of the mutated 
G proteins to near wild type levels.  Interestingly, previous studies pertaining to the role 
of the C-tail of VSV G in virus assembly examined truncation mutants in which one of 
those mutants was a G protein with a truncated C-tail of only 9 amino acids (CT9) (Whitt 
1989).  This mutant was also expressed on the surface at significantly reduced levels. 
Infectivity was measured by the ability of the mutant G protein to rescue infectivity of the 
tsO45 mutant that was described in chapter 1.  A 10-fold reduction in titer was observed 
when the CT9 mutant was used to rescue infectivity of tsO45 as opposed to wild type 
GIND.  The authors conclude that the reduction in surface expression accounts for the 
reduction in viral titer (Whitt, Chong et al. 1989).  The next step in characterization of 
these mutants was to examine fusion capacity. 
 
Cell-cell fusion experiments revealed that the membrane fusion activity of the 
ΔH425/S438I and ΔH425/I426S/S438I was restored to near wild type levels at both pH 
6.0 and 5.2.  Interestingly, in this experiment, the ΔH425/S438I mutant was only 
expressed at approximately 60% that of wild type and still was able to fuse at a level 
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similar to that of wild type.  This finding suggests the level of surface expression is not 
the primary determinant for efficient fusion of these mutated G proteins.  Alternately, the 
mutation may have produced a G protein that is a hyperfuser and therefore able to 
overcome reduced surface expression levels by fusing with greater efficiency.  Likewise, 
the finding may also indicate a level of expression that is sufficient to drive near wild 
type levels of fusion.  Further examination of levels of expression in correlation to fusion 
activity of G protein would be necessary to address these possibilities.  The 
F440A/F441A/S438I mutant also showed a restoration in fusion at pH 6.0.  The S438I 
mutation appears to enable the virus to overcome the decrease in threshold pH required 
for fusion to occur.  Perhaps the added hydrophbicity of the isoleucine at this position 
allows for interaction with either the target membrane or the viral membrane during the 
fusion process, causing destabilization of the membrane and promoting membrane fusion. 
 
Cell-cell fusion activity at pH 6.0 was not observed to be restored in the other 
mutants examined; F440V/F441A, F440T/F441A, or F440A/F441A/CT9.  Since these 
viruses likely outgrew the F440A/F441A mutant virus, some added benefit appears to 
have arisen with the additional mutations.  Phenyalanine residues are able to interact with 
other aromatic amino acids containing free pi electrons.  The two phenylalanines at 
positions 440 and 441 could have formed interactions with other aromatic residues that 
are nearby in the post fusion structure for stabilization.  Without these phenylalanines, the 
protein may rely on other interactions to provide stability which allows for more efficient 
fusion.  Perhaps the alanines mutate to valine or threonine respectively due to the larger 
size of these residues which in turn positions other residues within the protein in close 
proximity for interactions.  Further studies would be helpful in addressing theses 
possibilities. 
 
Surprisingly, F440A/F441A/CT9 was not enhanced in either cell surface 
expression or cell-cell fusion capacity. The cytoplasmic domain of viral fusion proteins 
such as Alphaviruses (Zhao, Lindqvist et al. 1994) and Retroviruses (Cosson 1996) have 
been shown to be important factors in the efficient budding of progeny virus. Since 
previous studies examining the length requirement for the C-terminus of VSV G 
indicated at least 9 residues are required for the efficient incorporation of G into virions 
(Whitt, Chong et al. 1989) the CT9 mutant should be incorporated efficiently.  The 
question as to the advantage this rapidly acquired mutation provides still remains.  One 
possibility is the shorter C-tail is better positioned to interact with the cell membrane 
which in effect aids in the membrane curvature required for budding of progeny virus.  
However, one would expect to have seen an enhancement in virus budding in the 
previous study using a CT9 mutant, so this is likely not the case.  Further experimentation 
would be needed to identify the advantage gained by acquiring the CT9 mutation in the 
F440A/F441A encoding virus. 
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Chapter 5: General Discussion 
 
 
Involvement of G Protein in VSV Infection 
 
Vesicular stomatitis virus is an enveloped virus that must undergo a fusion event 
mediated by the outer surface protein, G, to gain access into a host cell.  Viral fusion in 
enveloped viruses has been widely studied, with Influenza HA being the first fusion 
protein to be extensively characterized (Wiley, Wilson et al. 1981; Wilson, Skehel et al. 
1981).  Viral fusion proteins are required for entry into the host cell and function by 
mediating the membrane merger event between the viral membrane and the host cell 
membrane.  Crystal structure data for fusion proteins has provided much insight as to 
mechanisms by which these proteins may mediate viral entry, a critical step in the life 
cycle of the virus.  However, since no crystal structure data is available for the 
membrane-proximal region of these proteins, little is understood in regard to the exact 
role of this region in membrane fusion.  Previous mutational analyses of VSV G have 
suggested a direct contribution of the membrane-proximal region of the protein to the 
fusion and budding processes (Robison and Whitt 2000; Jeetendra, Robison et al. 2002; 
Jeetendra, Ghosh et al. 2003).  I am proposing a model for the contribution of the 
membrane-proximal region of G in host cell entry of VSV.  
 
 
VSV G Mediated Entry.  Vesicular stomatitis virus enters host cells through receptor-
mediated endocytosis (Matlin, Reggio et al. 1982).  The glycoprotein, G, on the outer 
membrane of the virus binds the host cell through an unknown receptor (Coil and Miller 
2004), is endocytosed by clathrin coated vesicles and transported through the endocytic 
pathway (Matlin, Reggio et al. 1982).  Evidence from our lab (Mire 2008), as well as 
others, suggests the fusion event occurs within the acidic environment of the early 
endosomes while another group argues transport to late endosomes is required (Le Blanc, 
Luyet et al. 2005).  Upon acidification of the endosome, a reversible conformational 
change in the G protein is triggered.  The reversible nature of this conformational change 
is a unique feature of the G protein that has not been observed in other viral fusion 
proteins (Roche and Gaudin 2002).  Once the initial conformational changes occur, the 
fusion peptide is thought to insert into the target membrane allowing for further 
conformational changes that pull the two membranes together.  A fusion pore is formed 
and the viral ribonucleocapsid is released into the host cell cytosol where replication 
takes place.  The solution of G protein crystal structures of G in both pre- and post fusion 
forms (Roche, Bressanelli et al. 2006; Roche, Rey et al. 2007) resulted in the 
classification of a third group of fusion proteins.  Fusion proteins that do not fit into class 
I or class II but have structural homology to VSV G in the post fusion structure are 
grouped into this class, as well.  Further elucidation of the VSV G-mediated fusion 
mechanism hopefully will provide clues as to the entry processes of less understood 
viruses. 
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Prototypic Class III Fusion Protein.  The past few years have provided a wealth of 
groundbreaking research contributing greatly to our understanding of viral fusion.  As 
mentioned, a new class of fusion proteins (class III) has been identified based on 
determination of the crystal structures of G in the pre- and postfusion forms (Roche, Rey 
et al. 2007) and their homology to the postfusion form of Herpes virus gB (Heldwein, 
Lou et al. 2006).  More recently, the Baculovirus gp64 (Kadlec, Loureiro et al. 2008) and 
Epstein-Barr virus gB postfusion structures have been solved (Backovic, Longnecker et 
al. 2009) revealing similar postfusion structures to that  of VSV G and therefore are 
grouped in this class.  Since VSV G is the only protein in this new group of fusion 
proteins in which both the pre and postfusion crystal structures have been solved, it 
serves as the prototype.  However, we still have a number of gaps in understanding the 
exact pathway of VSV G mediated membrane fusion.  Intermediate structures of G 
protein in the transition from the pre-fusion to the postfusion state have yet to be 
identified and structural information is not available for the membrane-proximal region, 
leaving many unanswered questions.  We are uncertain as to the exact contribution of the 
membrane-proximal region in achieving the structural transitions leading to membrane 
fusion or perhaps even in the actual membrane merger event itself.  In an effort to further 
elucidate the membrane fusion pathway of VSV G, the prototypic class III fusion protein, 
I chose to employ a mutagenesis approach focusing on the membrane-proximal region to 
identify the possible role of specific residues within this highly conserved region. 
 
 
VSV G Mediated Membrane Fusion Model 
 
Based on the available structural data and our recent findings, we have developed 
a model for the events leading to VSV G mediated membrane fusion (Fig 5-1).  VSV G 
trimers are embedded in the envelope of the virus and thought to sit on the surface of the 
virion forming “tripods” (Roche, Bressanelli et al. 2006) (Step 1).  The fusion domains 
serve as legs of the tripod with the membrane proximal regions positioned on the interior.  
The first step in G mediated membrane fusion is likely the binding of G to a phospholipid 
or other ubiquitious molecule on the cell surface (Schlegel, Willingham et al. 1982; 
Carneiro, Bianconi et al. 2002; Coil and Miller 2004). Once bound to the cell surface the 
virus is internalized via receptor mediated endocytosis (Matlin, Reggio et al. 1982).  At 
this stage in the fusion pathway G is likely still in the prefusion conformation that is 
believed to be stabilized by noncovalent interactions between the fusion domain and the 
membrane-proximal region (Roche, Bressanelli et al. 2006).  As the pH decreases within 
the endosome a conformational change occurs in G that exposes the bipartite fusion 
loops, enabling them to be inserted into the target membrane (Step 2).   
 
The next step is the clustering of G trimers at the fusion site.  Previous reports in 
rabies virus indicate a requirement of 13 to 19 G trimers for membrane fusion (Gaudin, 
Tuffereau et al. 1991).  The sequestering of a number of fusion proteins is seen in other 
viruses such as SFV E1, which has been shown to form rings of 5 to 6 trimers (Gibbons, 
Reilly et al. 2004; Kielian and Rey 2006).  Similarly, a need for clustering of fusion 
protein trimers has been observed in TBE E (Stiasny, Kiermayr et al. 2006).  When only 
the C-tail, transmembrane domain, and membrane-proximal region of G are expressed,  
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Figure 5-1.  Model for VSV G mediated membrane fusion.  (Step 1) G trimers sit on 
the virion surface like “tripods”.  This model shows the fusion domains (blue) on the 
interior of the trimer and extending downward toward the virion membrane.  The C-
terminal domain is extending out of the virion envelope and likely forming interactions 
with the fusion domain to stabilize the prefusion structure.  (Step 2) Once exposed to the 
low pH environment of the endosome a conformational change occurs releasing the 
fusion peptide and allowing for insertion into the target membrane.  (Step 3) G trimers 
cluster at the fusion site possibly through lateral interactions of the membrane-proximal 
domain.  (Step 4) As the pH decreases in the endosome further conformational changes 
occur that pulls the two membranes together, forming a hemifusion intermediate.  (Step 
5) Protonation of specific histidine residues leading to the formation of salt bridges with 
acidic residues in close proximity “lock” the low pH structure in place, allowing for 
fusion pore formation. 
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the truncated mutant is able to form trimers on the virion surface (Robison and Whitt 
2000).  The ability of this mutant to form trimers indicates that the residues within the 
truncated ectodomain can likely form interactions.  Based on these findings, one 
hypothesis for a role of the membrane-proximal region of G is to recruit enough G 
trimers to the fusion site to allow for fusion.  At this stage, the fusion protein is forming a 
“pre-hairpin intermediate” and is in an extended structure.  The conformation of G then 
changes from the extended state that allows for insertion into the target membrane by 
folding back on itself, bringing the C-terminal end and the fusion domain together.  The 
dramatic conformational change pulls the two opposing membranes into close proximity 
causing the initial lipid mixing, or hemifusion (step 3).   
 
Histidine protonation has been suggested to drive this low pH-induced structural 
transition (Carneiro, Stauffer et al. 2003).  Upon protonation of specific histidine 
residues, initial interactions are released, exposing the fusion loops.  The protein then 
folds back on itself and the newly protonated histidines come into proximity with acidic 
residues in which they can form salt bridges.  Formation of these interactions stabilizes 
this “hairpin” structure so that the highly unfavorable event, membrane merger, can occur 
(step 5).  Histidine has a pKa of 6 indicating that when G is exposed to low pH this 
residue becomes protonated (Carneiro, Stauffer et al. 2003).  The small pH range 
required for the conformational changes to occur suggests the protonation of only a few 
ionizable groups is required for the structural changes to occur in G.  I hypothesize that G 
undergoes the initial conformational changes driven by protonation of histidine residues, 
such as H148 and H149, (Carneiro, Stauffer et al. 2003) but that protonation of H423 
perhaps “locks” this postfusion conformation long enough to allow for outer lipid mixing, 
then pore formation, leading to release of the nucleocapsid into the host cell cytoplasm.  
When H423 is deleted (in the mutant ΔH423/P424/H425) no cell-cell fusion is observed.  
The mutated protein is still observed to undergo pH dependent conformational changes 
suggesting the residue is not critical for the low pH induced changes, but perhaps for 
maintaining the stability of the low pH form.  The DDE motif examined in chapter 3 
could possibly serve to interact with the newly protonated histidine residues to “lock” the 
protein in the post-fusion structure.  The last step in the fusion process is the complete 
mixing of the inner and outer leaflets of the two membranes and formation of a fusion 
pore in which the viral RNP can pass through for release into the host cell cytoplasm.  
 
 
Rapid Acquisition of Growth Enhancing Mutations 
 
RNA viruses have a very rapid mutation rate due to the error prone RNA 
dependent RNA polymerase used for replication.  This high rate of mutation likely 
enables the virus to adapt to a constantly changing environment.  Vesicular stomatitis 
virus serves as an attractive candidate for gene therapy and therefore examination of the 
rate of mutation has been widely studied.  Our findings suggest mutations made to the 
membrane-proximal region of the virus, producing less infectious virus, are rapidly 
compensated for through the incorporation of additional mutations.  Some of these 
rapidly acquired mutations appeared to overcome the fusion defect of the original desired 
mutation (F440A/F441A/S438I, ΔH425/S438I, and ΔH425/I426S/S438I).  However, 
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other mutations arose that showed the same fusion phenotype as was observed for the 
original intended mutant (F440V/F441A, F440A/F441A/CT9, and F440T/F441A).  
These data indicate that the mutations made to the membrane-proximal region of the G 
protein affected another stage of the viral life cycle.  The viruses with the same fusion 
defect as the F440A/F441A mutants were able to outgrow their respective parent virus 
indicating the mutation still provided some benefit, at a stage after the fusion event that 
enabled the virus to be more infectious.  The original constructed mutation resulted in a 
decrease in the threshold pH required to trigger fusion between the virus membrane and 
the host cell endosomal membrane.  Previous work in our lab has shown that mutations 
made to G protein causing a reduction in the pH at which fusion occurs resulted in 
production of less infectious virus (Fredericksen and Whitt 1995).  The likely reason for 
the decrease in viral titers observed for those viruses expressing mutated G proteins with 
a reduced pH threshold for fusion is the release of the RNP at a later time point in the 
endocytic pathway.  As the virus traverses the endocytic pathway, the pH drops.  When 
the pH reaches between 6.2 and 6.3 the viral membrane undergoes a fusion event with the 
host cell endosomal membrane, releasing the viral genetic information in to the cell 
cytoplasm where replication takes place.  A G protein with mutations resulting in the 
requirement of a lower pH for fusion would cause the RNP to be released at a different 
point within the endocytic pathway.  The fusion defect could possibly thereby have 
resulted in a replication, assembly, or budding defect.  The additional mutations that 
arose could compensate for the fusion defect as was observed for the mutants that 
acquired the S428I mutation.  However, the F440V/F441A and F440T/F441A mutants 
did not have restoration of fusion at the optimal pH for wild type G protein.   These 
viruses outgrew the F440A/F441A mutant virus indicating the viruses may have mutated 
to overcome the possible replication, assembly, or budding defect that resulted from the 
decrease in the pH required for fusion.  The rapid rate in which the additional mutations 
arise confirms our hypothesis that the membrane-proximal residues are critical to 
membrane fusion and infectivity of VSV.   
 
 
Role of GS in VSV Infection 
 
Studies involving GS have shown that this truncated G protein is present on the 
wild type VSV virion and can form trimers (Metsikko and Simons 1986; Robison and 
Whitt 2000).  GS, when expressed independently, can bind host cells, induce hemifusion, 
and potentiate cell-cell fusion when co-expressed with a fusion protein that cannot 
mediate fusion on its own (Robison and Whitt 2000).  Due to the interesting 
characteristics of this truncated G protein, questions have arisen in regard to its 
contribution to infection (if any).  The mutational analysis conducted in chapter 3 
revealed a G protein that, when D437, D438, and E439 are mutated to alanines, results in 
a reduction in cell-cell fusion activity.  This phenotype, however, did not correlate with 
what was seen in the virus.  The recombinant virus encoding this mutant G protein grew 
to titers similar to that of wild type and formed large plaques when examined by standard 
plaque assays.  Immunoblots of purified virus revealed a significantly larger amount of a 
C-tail antibody reactive protein which, based on its size, represents GS, than what was 
seen in wild type VSV.  We were unable to successfully immunoblot transiently 
76 
transfected cells to determine if G is being cleaved in the context of a viral infection or if 
this same cleavage product can be detected in the transiently transfected cells.  One 
possible explanation for the disconnect in data between the fusion assays performed on 
transiently transfected cells and the ability of the virus to grow and spread is the ability of 
GS to potentiate the fusion of viral fusion proteins that cannot fuse independently.  
Previous reports proposed a model, based on the ability of GS to bind cells, form trimers, 
and induce hemifusion, suggesting that GS interacts with the target membrane causing 
destabilization (Jeetendra, Robison et al. 2002).   
 
A cleavage site for G, producing GS, has yet to be identified.  Therefore, it is not 
known at what location in the cell G protein is truncated.  Many viral fusion proteins are 
proteolytically cleaved during transport through the secretory pathway by furin.  Furin is 
a calcium dependent serine endoprotease that cleaves just downstream of Arg – X- 
(Lys/Arg) – Arg and is enriched in the Golgi.  If the DDE mutant G protein is being 
cleaved by furin resulting in enhanced GS production, the truncated protein likely would 
be observed in the transiently expressing cells since the furin cleavage occurs in the 
secretory pathway.  Therefore, any affect on fusion capacity would likely be observed in 
cells transiently expressing the mutant G protein.  Another possibility could be cleavage 
occurring by enzymes within the acidic envoironment of the endosomes.  Since the DDE 
mutant has a reduced pH threshold for fusion the virus would travel further on the 
endocytic pathway. The mutated G protein could be exposed to enzymes within the late 
endosomes/lysosomes that cleave G forming GS.  This theory could explain the 
disconnect in data between cell-cell fusion assays using transiently transfected cells 
versus those infected with recombinant virus.  Regardless of the means by which G is 
cleaved, the experiments in chapter 3 suggest that the increased level of GS on the virion 
surface helps the virus overcome the fusion defect resultant from the 
D435A/D436A/E437A mutation.  We developed a model suggesting how the GS protein 
could aid in the VSV G mediated fusion process. 
 
Figure 5-2 depicts how GS could enhance fusion/entry of VSV G by either 
binding to and destabilizing the target membrane on the outside of the trimers (Fig 5-2A), 
or interacting with the viral membrane to cause destabilization (Fig 5-2B).  Alternatively, 
GS could be positioned on the inside of the “tripod” and as the membranes are being 
pulled together the truncated protein could interact with the target membrane causing 
destabilization and in effect help in the membrane merger event (Fig 5-2C).  However, 
our data merely suggests this possibility and further studies would need to be done to 
draw further conclusions. 
 
 
Future Experiments 
 
To further examine steps in the VSV G mediated vius-cell membrane fusion 
pathway it would be helpful to identify structural intermediates in the transition from the 
prefusion form to the low pH conformation.  Identification of these intermediates could 
give further insight as to the contribution of the membrane proximal region.  
Determination of these intermediates in the structural rearrangements that lead to fusion 
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Figure 5-2.  Potential role of GS in VSV G mediated fusion.  VSV G trimers are 
initially present on the virion surface as “tripods” in their prefusion form.  Upon exposure 
to low pH, G undergoes a reversible conformational change that initially exposes the 
fusion peptide and allows for insertion into the target membrane.  (A) Once the fusion 
peptide has inserted into the target membrane it “folds back” on itself pulling the two 
opposing membranes together.  One potential role of GS (shown in red) in VSV G 
mediated fusion is destabilization of the target membrane when the two membranes are 
initially being pulled together.  (B) Alternately, GS could lay parallel to the virion 
membrane and interact with the viral envelope to enhance the membrane fusion activity 
of G.  (C) GS could also participate by destabilizing the target membrane at the site 
where the two opposing membranes are being pulled together. 
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could also provide clues as to the pathway of the other newly characterized class III 
fusion proteins such as Herpes virus gB, Baculovirus gp64, and Epstein-Barr virus gB.  
A challenge in studying the transition from the pre- to postfusion conformational change 
in the G protein is the inability to detect intermediates with antibodies (as is seen in SFV 
E1, for example) Previous attempts at generating monoclonal antibodies to the membrane 
proximal region of G have been unsuccessful (personal communication with Mike 
Whitt).  Perhaps peptide inhibitors could be designed directed toward the membrane 
proximal region to determine if structural transitions could be blocked by the interference 
of the peptides, as seen with PIV-5 F (Russell, Jardetzky et al. 2001). 
 
Data in chapter 3 suggests a critical role of the conserved HPH motif (or just the 
histidines).  An experiment that would help examine the hypothesis that these histidines 
are involved in stabilization of the post fusion structure would be to do a 3-color fusion 
assay with ΔH423/P424/H425 (fusion defective) to detect if this fusion defective mutant 
is able to achieve hemifusion.  If this mutant were able to achieve hemifusion it would 
support the idea that the histidines or the HPH motif is important to stabilization of the 
final, low pH conformation.  Initial conformational changes would allow for insertion of 
the fusion peptide, further conformational changes would allow for hemifusion to be 
observed, however if the structure is not stabilized full fusion would not occur (as was 
observed in chapter 3).  Since I propose the mutated residues in chapter 3 are important to 
the low pH-induced conformational changes it would be helpful to do a trypsin-
sensitivity assay in which limiting amounts of trypsin is used to look at the stability of the 
conformational changes.   
   
I also think that additional mutations in the membrane proximal region could 
provide more conclusive evidence regarding specific residues in this region.  For 
example, H423 (the histidine proposed to form a salt bridge with D137) should be 
mutated to determine if this one histidine residue is critical to G-mediated membrane 
fusion.  Likewise, my model for VSV G mediated membrane fusion suggests the possible 
role of hydrophobic residues.  Further mutational analysis in which hydrophobic residues, 
such as F421, I426, L433, L439, and L446 are changed to alanines to identify if the 
hydrophobicity of this region plays a role in the virus-cell fusion pathway of G.  
Furthermore, it would be interesting to mutate the serine at position 438 (that was 
mutated to an isoleucine in several of the variants) to an isoleucine to see if an enhanced 
fusion or cell surface expression phenotype could be observed to explore the advantage 
of the amino acid change to virus entry.  The mutants from chapter 3 should also be 
examined for their budding capacity at early time points and experiments should be done 
to measure the replication capacity (real time PCR could be used to measure this).   
 
The D435A/D436A/D437A mutant provides the first possible evidence for a role 
for GS in the context of its natural expression on the virion surface.  However, the data 
(in chapter 3) only suggests the possibility that GS functions to enhance fusion activity 
(possibly even more when environmental pressures are limiting the ability of the virus to 
grow and spread efficiently).  Unfortunately, experiments in which detection of GS in 
cells transiently transfected with either wild type G or D435A/D436A/E437A were 
unsuccessful, leaving doubt as to the level of cleaved G (GS) on the cell surface in the 
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context of transient expression.  Optimization of this experiment should be explored by 
immunoprecipitating the protein from overexpressing cells.  One problem in the 
experiment has been the amount of protein is very small making detection challenging.  
Likewise, when the experiment is done on cell lysates that have not been 
immunoprecipitated non-specific interactions are detected preventing visualization of GS.   
 
An experiment that would help determine the proximity of GS on the virion (or 
cell) surface is the use of electonmicroscopy with immunogold labeling This suggestion 
is based on experiments done by Dr. Doug Lyles (Wake Forest University) that identified 
the localization of G in microdomains on the virion surface (Brown and Lyles 2003). 
This experiment would answer the question as to whether G and GS are even located in 
the same microdomains to determine if both proteins are even present at the fusion site 
simultaneously. 
 
In conclusion, these studies have given further insight to the VSV G mediated 
membrane fusion pathway by identifying residues within the membrane-proximal region 
of which no structural information is available.  Gaining a better understanding of the G-
mediated fusion event also can give provide clues as to the mechanisms other class III 
fusion proteins utilize, in particular human pathogens such as herpes simplex Epstein-
Barr viruses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
81 
List of References 
 
 
Allison, S. L., J. Schalich, et al. (1995). "Oligomeric rearrangement of tick-borne 
encephalitis virus envelope proteins induced by an acidic pH." J Virol 69(2): 695-
700. 
Bach, M., P. Bringmann, et al. (1990). "Purification of small nuclear ribonucleoprotein 
particles with antibodies against modified nucleosides of small nuclear RNAs." 
Methods Enzymol. 181: 232-257. 
Backovic, M., R. Longnecker, et al. (2009). "Structure of a trimeric variant of the 
Epstein-Barr virus glycoprotein B." Proc Natl Acad Sci U S A 106(8): 2880-2885. 
Balch, W. E. (1989). "Biochemistry of interorganelle transport. A new frontier in 
enzymology emerges from versatile in vitro model systems." J Biol Chem 264: 
16965-16968. 
Berger, E. A. (1998). "And the best picture is--the HIV gp120 envelope, please!" Nat 
Struct Biol 5(8): 671-674. 
Berger, E. A., P. M. Murphy, et al. (1999). "Chemokine receptors as HIV-1 coreceptors: 
roles in viral entry, tropism, and disease." Annu Rev Immunol 17: 657-700. 
Bhella, R. S., S. T. Nichol, et al. (1998). "Structure, expression and phylogenetic analysis 
of the glycoprotein gene of Cocal virus." Virus Res 54(2): 197-205. 
Bilsel, P. A. and S. T. Nichol (1990). "Polymerase errors accumulating during natural 
evolution of the glycoprotein gene of vesicular stomatitis virus Indiana serotype 
isolates." J Virol 64(10): 4873-4883. 
Blumenthal, R., D. P. Sarkar, et al. (1996). "Dilation of the influenza hemagglutinin 
fusion pore revealed by the kinetics of individual cell-cell fusion events." J Cell 
Biol 135(1): 63-71. 
Bottomley, M. J., K. Salim, et al. (1998). "Phospholipid-binding protein domains." 
Biochim Biophys Acta 1436(1-2): 165-183. 
Brown, E. L. and D. S. Lyles (2003). "Organization of the vesicular stomatitis virus 
glycoprotein into membrane microdomains occurs independently of intracellular 
viral components." J Virol 77(7): 3985-3992. 
Brun, G., X. Bao, et al. (1995). "The relationship of Piry virus to other vesiculoviruses: a 
re-evaluation based on the glycoprotein gene sequence." Intervirology 38: 274-
282. 
Bullough, P. A., F. M. Hughson, et al. (1994). "Structure of influenza haemagglutinin at 
the pH of membrane fusion." Nature 371: 37-43. 
Carneiro, F. A., M. L. Bianconi, et al. (2002). "Membrane recognition by vesicular 
stomatitis virus involves enthalpy-driven protein-lipid interactions." J Virol 76(8): 
3756-3764. 
Carneiro, F. A., F. Stauffer, et al. (2003). "Membrane fusion induced by vesicular 
stomatitis virus depends on histidine protonation." J Biol Chem 278(16): 13789-
13794. 
Carnell, L. and H. P. Moore (1994). "Transport via the regulated secretory pathway in 
semi-intact PC12 cells: role of intra-cisternal calcium and pH in the transport and 
sorting of secretogranin II." J Cell Biol 127(3): 693-705. 
82 
Carr, C. M., C. Chaudhry, et al. (1997). "Influenza hemagglutinin is spring-loaded by a 
metastable native conformation." Proc Natl Acad Sci (USA) 94(26): 14306-
14313. 
Chan, D. C., D. Fass, et al. (1997). "Core structure of gp41 from the HIV envelope 
glycoprotein." Cell 89(2): 263-273. 
Chen, S. S. L., N. Ariel, et al. (1988). "Membrane anchors of vesicular stomatitis virus: 
characterization and incorporation into virions." J Virol 62: 2552-2556. 
Chernomordik, L. V., G. B. Melikyan, et al. (1987). "Biomembrane fusion: a new 
concept derived from model studies using two interacting planar lipid bilayers." 
Biochim Biophys Acta 906(3): 309-352. 
Choe, H., M. Farzan, et al. (1996). "The beta-chemokine receptors CCR3 and CCR5 
facilitate infection by primary HIV-1 isolates." Cell 85(7): 1135-1148. 
Coil, D. A. and A. D. Miller (2004). "Phosphatidylserine is not the cell surface receptor 
for vesicular stomatitis virus." J Virol 78(20): 10920-10926. 
Corey, E. A., A. M. Mirza, et al. (2003). "Fusion deficiency induced by mutations at the 
dimer interface in the Newcastle disease virus hemagglutinin-neuraminidase is 
due to a temperature-dependent defect in receptor binding." J Virol 77(12): 6913-
6922. 
Corver, J., A. Ortiz, et al. (2000). "Membrane fusion activity of tick-borne encephalitis 
virus and recombinant subviral particles in a liposomal model system." Virology 
269(1): 37-46. 
Cosson, P. (1996). "Direct interaction between the envelope and matrix proteins of HIV-
1." Embo J 15(21): 5783-5788. 
Crise, B., A. Ruusala, et al. (1989). "Oligomerization of glycolipid-anchored and soluble 
forms of the vesicular stomatitis virus glycoprotein." J Virol 63: 5328-5333. 
Cross, K. J., S. A. Wharton, et al. (2001). "Studies on influenza haemagglutinin fusion 
peptide mutants generated by reverse genetics." EMBO J 20(16): 4432-4442. 
Daniels, T. S., J. C. Downie, et al. (1985). "Fusion mutants of the influenza virus 
hemagglutinin glycoprotein." Cell 40: 431-439. 
de Silva, A., I. Braakman, et al. (1993). "Posttranslational folding of vesicular stomatitis 
virus G protein in the ER: involvement of noncovalent and covalent complexes." J 
Cell Biol 120: 647-655. 
de Silva, A. M., W. E. Balch, et al. (1990). "Quality control in the endoplasmic 
reticulum: folding and misfolding of vesicular stomatitis virus G protein in cells 
and in vitro." J Cell Biol 111: 857-866. 
Decroly, E., M. Vandenbranden, et al. (1994). "The convertases furin and PC1 can both 
cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 
into gp120 (HIV-1 SU) and gp41 (HIV-I TM)." J Biol Chem 269(16): 12240-
12247. 
Demaurex, N., W. Furuya, et al. (1998). "Mechanism of acidification of the trans-Golgi 
network (TGN). In situ measurements of pH using retrieval of TGN38 and furin 
from the cell surface." J Biol Chem 273(4): 2044-2051. 
Doms, R. W., D. S. Keller, et al. (1987). "Role for adenosine triphosphate in regulating 
the assembly and transport of vesicular stomatitis virus G protein trimers." J Cell 
Biol 105: 1957-1969. 
83 
Doms, R. W., A. Ruusala, et al. (1988). "Differential effects of mutations in three 
domains on folding, quaternary structure, and intracellular transport of vesicular 
stomatitis virus G protein." J Cell Biol. 107: 89-99. 
Doms, R. W. and D. Trono (2000). "The plasma membrane as a combat zone in the HIV 
battlefield." Genes Dev 14(21): 2677-2688. 
Drake, J. W. (1999). "The distribution of rates of spontaneous mutation over viruses, 
prokaryotes, and eukaryotes." Ann N Y Acad Sci 870: 100-107. 
Drake, J. W. and J. J. Holland (1999). "Mutation rates among RNA viruses." Proc Natl 
Acad Sci U S A 96(24): 13910-13913. 
Durrer, P., Y. Gaudin, et al. (1995). "Photolabeling identifies a putative fusion domain in 
the envelope glycoprotein of rabies and vesicular stomatitis viruses." J Biol Chem 
270(29): 17575-17581. 
Earp, L. J., S. E. Delos, et al. (2005). "The many mechanisms of viral membrane fusion 
proteins." Curr Top Microbiol Immunol 285: 25-66. 
Eckert, D. M. and P. S. Kim (2001). "Design of potent inhibitors of HIV-1 entry from the 
gp41 N-peptide region." Proc Natl Acad Sci U S A 98(20): 11187-11192. 
Fredericksen, B. L. and M. A. Whitt (1995). Mutations affecting the pH threshold for 
vesicular stomatitis virus G protein mediated membrane fusion. 14th Annual 
American Society for Virology Meeting, Austin, TX. 
Fredericksen, B. L. and M. A. Whitt (1995). "Vesicular stomatitis virus glycoprotein 
mutations that affect membrane fusion activity and abolish virus infectivity." J 
Virol  69: 1435-1443. 
Fredericksen, B. L. and M. A. Whitt (1996). "Mutations at two conserved acidic amino 
acids in the glycoprotein of vesicular stomatitis virus affect pH-dependent 
conformational changes and reduce the pH threshold for membrane fusion." 
Virology 217: 49-57. 
Fredericksen, B. L. and M. A. Whitt (1998). "Attenuation of recombinant vesicular 
stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for 
maintaining a high pH threshold for membrane fusion in viral fitness." Virology 
240: 349-358. 
Fuerst, T. R., E. P.L., et al. (1987). "Use of a hybrid vaccinia virus-T7 RNA polymerase 
system for expression of target genes." Mol Cell Biol. 7: 2538-2544. 
Gallione, C. J. and J. K. Rose (1983). "Nucleotide sequence of a cDNA clone encoding 
the entire glycoprotein from the New Jersey serotype of vesicular stomatitis 
virus." J Virol 46: 162-169. 
Gaudin, Y., P. de Kinkelin, et al. (1999). "Mutations in the glycoprotein of viral 
haemorrhagic septicaemia virus that affect virulence for fish and the pH threshold 
for membrane fusion." J Gen Virol 80 ( Pt 5)(Pt 5): 1221-1229. 
Gaudin, Y., H. Raux, et al. (1996). "Identification of amino acids controlling the low-pH-
induced conformational change of rabies virus glycoprotein." J Virol 70: 7371-
7378. 
Gaudin, Y., C. Tuffereau, et al. (1991). "Reversible conformational changes and fusion 
activity of rabies virus glycoprotein." J Virol 65: 4853-4859. 
Gething, M. J., K. McCammon, et al. (1986). "Expression of wild-type and mutant forms 
of influenza hemagglutinin: the role of folding in intracellular transport." Cell 46: 
939-950. 
84 
Gibbons, D. L., B. Reilly, et al. (2004). "Purification and crystallization reveal two types 
of interactions of the fusion protein homotrimer of Semliki Forest virus." J Virol 
78(7): 3514-3523. 
Gravel, K. A. and T. G. Morrison (2003). "Interacting domains of the HN and F proteins 
of newcastle disease virus." J Virol 77(20): 11040-11049. 
Hallenberger, S., V. Bosch, et al. (1992). "Inhibition of furin-mediated cleavage 
activation of HIV-1 glycoprotein gp160." Nature 360(6402): 358-361. 
Harlan, J. E., P. J. Hajduk, et al. (1994). "Pleckstrin homology domains bind to 
phosphatidylinositol-4,5-bisphosphate." Nature 371(6493): 168-170. 
Heinz, F. X. and C. Kunz (2004). "Tick-borne encephalitis and the impact of 
vaccination." Arch Virol Suppl 18(18): 201-205. 
Heldwein, E. E., H. Lou, et al. (2006). "Crystal structure of glycoprotein B from herpes 
simplex virus 1." Science 313(5784): 217-220. 
Helenius, A. and J. Kartenbeck (1980). "The effects of octylglucoside on the Semliki 
Forest virus membrane: evidence for a spike-nucleocapsid interaction." Eur J 
Biochem. 106: 613-618. 
Hercyk, N., S. M. Horikami, et al. (1988). "The vesicular stomatitis virus L protein 
possesses the mRNA methyltransferase activities." Virology 163: 222-225. 
Hernandez, L. D., L. R. Hoffman, et al. (1996). "Virus-cell and cell-cell fusion." Ann 
Rev Cell Dev Biol. 12: 627-661. 
Huang, R. T., R. Rott, et al. (1981). "Influenza viruses cause hemolysis and fusion of 
cells." Virology 110(1): 243-247. 
Hughson, F. M. (1997). "Enveloped viruses: a common mode of membrane fusion?" Curr 
Biol 7(9): R565-569. 
Iverson, L. E. and J. K. Rose (1981). "Localized attenuation and discontinuous synthesis 
during vesicular stomatitis virus transcription." Cell 23: 477-484. 
Iverson, L. E. and J. K. Rose (1982). "Sequential synthesis of 5'-proximal vesicular 
stomatitis virus mRNA sequences." J Virol 44: 356-365. 
Jahn, R. and T. C. Sudhof (1999). "Membrane fusion and exocytosis." Annu Rev 
Biochem 68: 863-911. 
Jayakar, H. R. and M. A. Whitt (2002). "Identification of two additional translation 
products from the matrix (M) gene that contribute to vesicular stomatitis virus 
cytopathology." J Virol 76(16): 8011-8018. 
Jeetendra, E., K. Ghosh, et al. (2003). "The membrane-proximal region of vesicular 
stomatitis virus glycoprotein G ectodomain is critical for fusion and virus 
infectivity." J Virol 77(23): 12807-12818. 
Jeetendra, E., C. S. Robison, et al. (2002). "The membrane-proximal domain of vesicular 
stomatitis virus G protein functions as a membrane fusion potentiator and can 
induce hemifusion." J Virol 76(23): 12300-12311. 
Kadlec, J., S. Loureiro, et al. (2008). "The postfusion structure of baculovirus gp64 
supports a unified view of viral fusion machines." Nat Struct Mol Biol 15(10): 
1024-1030. 
Kampmann, T., D. S. Mueller, et al. (2006). "The Role of histidine residues in low-pH-
mediated viral membrane fusion." Structure 14(10): 1481-1487. 
Kearney, C. M., J. Donson, et al. (1993). "Low level of genetic drift in foreign sequences 
replicating in an RNA virus in plants." Virology 192(1): 11-17. 
85 
Kielian, M., S. Keranen, et al. (1984). "Membrane fusion mutants of Semliki Forest 
virus." J Cell Biol 98: 139-145. 
Kielian, M. and F. A. Rey (2006). "Virus membrane-fusion proteins: more than one way 
to make a hairpin." Nat Rev Microbiol 4(1): 67-76. 
Kim, J. H., L. Johannes, et al. (1998). "Noninvasive measurement of the pH of the 
endoplasmic reticulum at rest and during calcium release." Proc Natl Acad Sci U 
S A 95(6): 2997-3002. 
Kim, J. H., C. A. Lingwood, et al. (1996). "Dynamic measurement of the pH of the Golgi 
complex in living cells using retrograde transport of the verotoxin receptor." J 
Cell Biol 134(6): 1387-1399. 
Knipe, D. M., D. Baltimore, et al. (1977). "Maturation of viral proteins in cells infected 
with temperature- sensitive mutants of vesicular stomatitis virus." J Virol 21(3): 
1149-1158. 
Kuzmin, P. I., J. Zimmerberg, et al. (2001). "A quantitative model for membrane fusion 
based on low-energy intermediates." Proc Natl Acad Sci U S A 98(13): 7235-
7240. 
Lapham, C. K., J. Ouyang, et al. (1996). "Evidence for cell-surface association between 
fusin and the CD4-gp120 complex in human cell lines." Science 274(5287): 602-
605. 
Lawson, N. D., E. A. Stillman, et al. (1995). "Recombinant vesicular stomatitis viruses 
from DNA." Proc Natl Acad Sci (USA) 92(10): 4477-4481. 
Le Blanc, I., P. P. Luyet, et al. (2005). "Endosome-to-cytosol transport of viral 
nucleocapsids.[see comment]." Nature Cell Biology 7(7): 653-664. 
Lecocq-Xhonneux, F., M. Thiry, et al. (1994). "A recombinant viral haemorrhagic 
septicaemia virus glycoprotein expressed in insect cells induces protective 
immunity in rainbow trout." J Gen Virol 75 ( Pt 7)(Pt 7): 1579-1587. 
Lefrancois, L. and D. S. Lyles (1982). "The interaction of antibody with the major 
surface glycoprotein of vesicular stomatitis virus. I. analysis of neutralizing 
epitopes with monoclonal antibodies." Virology 121: 157-167. 
Lefrancois, L. and D. S. Lyles (1982). "The interaction of antibody with the major 
surface glycorprotein of vesicular stomatitis virus. II. monoclonal antibodies to 
nonneutralizing and cross-reactive epitopes of Indiana and New Jersey serotypes." 
Virology 121: 168-174. 
Lemmon, M. A. and K. M. Ferguson (2000). "Signal-dependent membrane targeting by 
pleckstrin homology (PH) domains." Biochem J 350 Pt 1: 1-18. 
Lentz, B. R., V. Malinin, et al. (2000). "Protein machines and lipid assemblies: current 
views of cell membrane fusion." Curr Opin Struct Biol 10(5): 607-615. 
Lescar, J., A. Roussel, et al. (2001). "The fusion glycoprotein shell of Semliki Forest 
virus: an icosahedral assembly primed for fusogenic activation at endosomal pH." 
Cell 105(1): 137-148. 
Li, Y., C. Drone, et al. (1993). "Mutational analysis of the vesicular stomatitis virus 
glycoprotein G for membrane fusion domains." J Virol 67: 4070-4077. 
Liao, M. and M. Kielian (2006). "Functions of the stem region of the Semliki Forest virus 
fusion protein during virus fusion and assembly." J Virol 80(22): 11362-11369. 
86 
Liao, M. and M. Kielian (2006). "Site-directed antibodies against the stem region reveal 
low pH-induced conformational changes of the Semliki Forest virus fusion 
protein." J Virol 80(19): 9599-9607. 
Lyles, D. S., M. McKenzie, et al. (1992). "Subunit interactions of vesicular stomatitis 
virus envelope glycoprotein stabilized by binding to viral matrix protein." J Virol 
66: 349-358. 
Lyles, D. S. and M. O. McKenzie (1998). "Reversible and irreversible steps in assembly 
and disassembly and vesicular stomatitis virus: equilibria and kinetics of 
dissociation of nucleocapsid-M protein complexes assembled in vivo." 
Biochemistry 37: 439-450. 
Lyles, D. S., V. A. Varela, et al. (1990). "Dynamic nature of the quaternary structure of 
the vesicular stomatitis virus envelope glycoprotein." Biochemistry 29: 2442-
2449. 
Machamer, C. E., R. W. Doms, et al. (1990). "Heavy chain binding protein recognizes 
incompletely disulfide-bonded forms of vesicular stomatitis virus G protein." J 
Biol Chem 265: 6879-6883. 
Maddon, P. J., A. G. Dalgleish, et al. (1986). "The T4 gene encodes the AIDS virus 
receptor and is expressed in the immune system and the brain." Cell 47: 333-348. 
Maddon, P. J., J. S. McDougal, et al. (1988). "HIV infection does not require endocytosis 
of its receptor, CD4." Cell 54(6): 865-874. 
Maeda, T. and S. Ohnishi (1980). "Activation of influenza virus by acidic media causes 
hemolysis and fusion of erythrocytes." FEBS Lett 122(2): 283-287. 
Marriott, A. C. (2005). "Complete genome sequences of Chandipura and Isfahan 
vesiculoviruses." Arch Virol 150(4): 671-680. 
Masters, P. S., R. S. Bhella, et al. (1989). "Structure and expression of the glycoprotein 
gene of Chandipura virus [published erratum appears in Virology 1990 
Feb;174(2):630]." Virology 171(1): 285-290. 
Mathieu, M. E., P. R. Grigera, et al. (1996). "Folding, unfolding, and refolding of the 
vesicular stomatitis virus glycoprotein." Biochemistry 35(13): 4084-4093. 
Matlin, K., H. Reggio, et al. (1982). "The pathway of vesicular stomatitis entry leading to 
infection." J Mol Biol 156: 609-631. 
Matlin, K. S., H. Reggio, et al. (1982). "Pathway of vesicular stomatitis virus entry 
leading to infection." J Mol Biol 156(3): 609-631. 
McClure, M. O., M. Marsh, et al. (1988). "Human immunodeficiency virus infection of 
CD4-bearing cells occurs by a pH-independent mechanism." EMBO J 7(2): 513-
518. 
Melikyan, G. B., R. M. Markosyan, et al. (2000). "Evidence that the transition of HIV-1 
gp41 into a six-helix bundle, not the bundle configuration, induces membrane 
fusion." J Cell Biol 151(2): 413-423. 
Melikyan, G. B., W. D. Niles, et al. (1993). "Influenza virus hemagglutinin-induced cell-
planar bilayer fusion: quantitative dissection of fusion pore kinetics into stages." J 
Gen Physiol 102(6): 1151-1170. 
Melikyan, G. B., W. D. Niles, et al. (1993). "Influenza hemagglutinin-mediated fusion 
pores connecting cells to planar membranes: flickering to final expansion." J Gen 
Physiol 102(6): 1131-1149. 
87 
Metsikko, K. and K. Simons (1986). "The budding mechanism of spikeless vesicular 
stomatitis virus particles." EMBO J. 5: 1913-1920. 
Mire, Chad E., "Investigation of the vesicular stomatitis virus matrix protein: uncoating 
and assembly" (Ph.D. dissertation, University of Tennessee Health Science 
Center, 2008), 44-56. 
Miyauchi, K., Y. Kim, et al. (2009). "HIV enters cells via endocytosis and dynamin-
dependent fusion with endosomes." Cell 137(3): 433-444. 
Nieva, J. L., R. Bron, et al. (1994). "Membrane fusion of Semliki Forest virus requires 
sphingolipids in the target membrane." Embo J 13(12): 2797-2804. 
Odenwald, W. F., H. Arnheiter, et al. (1986). "Stereo images of vesicular stomatitis virus 
assembly." J Virol 57: 922-932. 
Porotto, M., M. Murrell, et al. (2005). "Influence of the human parainfluenza virus 3 
attachment protein's neuraminidase activity on its capacity to activate the fusion 
protein." J Virol 79(4): 2383-2392. 
Qin, Z. L., Y. Zheng, et al. (2009). "Role of conserved histidine residues in the low-pH 
dependence of the Semliki Forest virus fusion protein." J Virol 83(9): 4670-4677. 
Quinones-Kochs, M. I., M. J. Schnell, et al. (2001). "Mechanisms of loss of foreign gene 
expression in recombinant vesicular stomatitis viruses." Virology 287(2): 427-
435. 
Rebecchi, M. J. and S. Scarlata (1998). "Pleckstrin homology domains: a common fold 
with diverse functions." Annu Rev Biophys Biomol Struct 27: 503-528. 
Reithmeier, R. A. (1995). "Characterization and modeling of membrane proteins using 
sequence analysis." Curr Opin Struct Biol 5(4): 491-500. 
Rigaut, K. D., D. E. Birk, et al. (1991). "Intracellular distribution of input vesicular 
stomatitis virus proteins after uncoating." J Virol 65: 2622-2628. 
Robison, C. S. and M. A. Whitt (2000). "The membrane-proximal stem region of 
vesicular stomatitis virus G protein confers efficient virus assembly." J Virol 74: 
2239-2246. 
Roche, S., S. Bressanelli, et al. (2006). "Crystal structure of the low-pH form of the 
vesicular stomatitis virus glycoprotein G." Science 313(5784): 187-191. 
Roche, S. and Y. Gaudin (2002). "Characterization of the equilibrium between the native 
and fusion-inactive conformation of rabies virus glycoprotein indicates that the 
fusion complex is made of several trimers." Virology 297(1): 128-135. 
Roche, S., F. A. Rey, et al. (2007). "Structure of the prefusion form of the vesicular 
stomatitis virus glycoprotein G." Science 315(5813): 843-848. 
Rose, J. K., L. Buonocore, et al. (1991). "A new cationic liposome reagent mediating 
nearly quantitative transfection of animal cells." BioTechniques 10: 520-525. 
Rose, J. K., R. F. Doolittle, et al. (1982). "Homology between the glycoproteins of 
vesicular stomatitis virus and rabies virus." J Virol 43: 361-364. 
Rose, J. K. and C. J. Gallione (1981). "Nucleotide sequences of the mRNA's encoding the 
vesicular stomatitis virus G and M proteins determined from cDNA clones 
containing the complete coding regions." J Virol 39: 519-528. 
Rose, J. K., W. J. Welch, et al. (1980). "Vesicular stomatitis virus glycoprotein is 
anchored in the viral membrane by a hydrophobic domain near the COOH 
terminus." Proc Natl Acad Sci USA 77: 3884-3888. 
88 
Rose, J. K. and M. A. Whitt (2001). Rhabdoviridae: the viruses and their replication. 
Field's Virology. D. Knipe and P. M. Howley. Philadelphia, Lippincott Williams 
& Wilkins. 1: 1221-1244. 
Roussel, A., J. Lescar, et al. (2006). "Structure and interactions at the viral surface of the 
envelope protein E1 of Semliki Forest virus." Structure 14(1): 75-86. 
Ruigrok, R. W., N. G. Wrigley, et al. (1986). "Electron microscopy of the low pH 
structure of influenza virus haemagglutinin." Embo J 5(1): 41-49. 
Russell, C. J., T. S. Jardetzky, et al. (2001). "Membrane fusion machines of 
paramyxoviruses: capture of intermediates of fusion." Embo J 20(15): 4024-4034. 
Salminen, A., J. M. Wahlberg, et al. (1992). "Membrane fusion process of Semliki Forest 
virus. II: cleavage-dependent reorganization of the spike protein complex controls 
virus entry." J Cell Biol 116(2): 349-357. 
Salzwedel, K., J. T. West, et al. (1999). "A conserved tryptophan-rich motif in the 
membrane-proximal region of the human immunodeficiency virus type 1 gp41 
ectodomain is important for Env-mediated fusion and virus infectivity." J Virol 
73(3): 2469-2480. 
Schlegel, R., M. C. Willingham, et al. (1982). "Saturable binding sites for vesicular 
stomatitis virus on the surface of Vero cells." J Virol 43(3): 871-875. 
Schnell, M. J., L. Buonocore, et al. (1996). "The minimal conserved transcription stop-
start signal promotes stable expression of a foreign gene in vesicular stomatitis 
virus." J Virol 70(4): 2318-2323. 
Schnell, M. J., J. E. Johnson, et al. (1997). "Construction of a novel virus that targets 
HIV-1-infected cells and controls HIV-1 infection [see comments]." Cell 90(5): 
849-857. 
Schubert, M., J. D. Keene, et al. (1980). "Site of the vesicular stomatitis virus genome 
sqecifying polyadenylation and the end of the L gene mRNA." J Virol 34: 550-
559. 
Seksek, O., J. Biwersi, et al. (1996). "Evidence against defective trans-Golgi acidification 
in cystic fibrosis." J Biol Chem 271(26): 15542-15548. 
Shokralla, S., R. Chernish, et al. (1999). "Effects of double-site mutations of vesicular 
stomatitis virus glycoprotein G on membrane fusion activity." Virology 256(1): 
119-129. 
Skehel, J. J. and D. C. Wiley (1998). "Coiled coils in both intracellular vesicle and viral 
membrane fusion." Cell 95(7): 871-874. 
Skehel, J. J. and D. C. Wiley (2000). "Receptor binding and membrane fusion in virus 
entry: the influenza hemagglutinin." Annu Rev Biochem 69: 531-569. 
Smith, A. E. and A. Helenius (2004). "How viruses enter animal cells." Science 
304(5668): 237-242. 
Spiropoulou, C. F. and S. T. Nichol (1993). "A small highly basic protein is encoded in 
overlapping frame within the P gene of vesicular stomatitis virus." J Virol 67: 
3103-3110. 
Stadler, K., S. L. Allison, et al. (1997). "Proteolytic activation of tick-borne encephalitis 
virus by furin." J Virol 71(11): 8475-8481. 
Stein, B. S., S. D. Gowda, et al. (1987). "pH-independent HIV entry into CD4-positive T 
cells via virus envelope fusion to the plasma membrane." Cell 49(5): 659-668. 
89 
Steinhauer, D. A., J. C. De La Torre, et al. (1989). "High nucleotide substitution error 
frequencies in clonal pools of vesicular stomatitis virus." J Virol 63(5): 2063-
2071. 
Stiasny, K., S. Kiermayr, et al. (2006). "Cryptic properties of a cluster of dominant 
flavivirus cross-reactive antigenic sites." J Virol 80(19): 9557-9568. 
Stiasny, K., C. Koessl, et al. (2003). "Involvement of lipids in different steps of the 
flavivirus fusion mechanism." J Virol 77(14): 7856-7862. 
Swinteck, B.D. and D.S. Lyles (2008).  "Plasma membrane microdomains containing 
vesicular stomatitis virus M protein are separate from microdomains containing G 
protein and nucleocapsids." J Virol 82(11): 5536-5547. 
Takada, A., C. Robison, et al. (1997). "A novel system for functional analysis of Ebola 
virus glycoprotein." Proc Natl Acad Sci  USA 94: 14764-14769. 
Takimoto, T., G. L. Taylor, et al. (2002). "Role of the hemagglutinin-neuraminidase 
protein in the mechanism of paramyxovirus-cell membrane fusion." J Virol 
76(24): 13028-13033. 
Thomas, D., W. W. Newcomb, et al. (1985). "Mass and molecular composition of 
vesicular stomatitis virus: a scanning transmission electron microscopy analysis." 
J Virol 54: 598-607. 
Trkola, A., T. Dragic, et al. (1996). "CD4-dependent, antibody-sensitive interactions 
between HIV-1 and its co-receptor CCR-5." Nature 384(6605): 184-187. 
Wahlberg, J. M., R. Bron, et al. (1992). "Membrane fusion of Semliki Forest virus 
involves homotrimers of the fusion protein." J Virol 66: 7309-7318. 
Weissenhorn, W., A. Dessen, et al. (1997). "Atomic structure of the ectodomain from 
HIV-1 gp41." Nature 387(6631): 426-430. 
Wengler, G. and G. Wengler (1989). "Cell-associated West Nile flavivirus is covered 
with E+pre-M protein heterodimers which are destroyed and reorganized by 
proteolytic cleavage during virus release." J Virol 63(6): 2521-2526. 
White, J., K. Matlin, et al. (1981). "Cell fusion by Semliki Forest, influenza and vesicular 
stomatitis virus." J Cell Biol 89: 674-679. 
White, J. M., S. E. Delos, et al. (2008). "Structures and mechanisms of viral membrane 
fusion proteins: multiple variations on a common theme." Critical Reviews in 
Biochemistry & Molecular Biology 43(3): 189-219. 
Whitt, M. A., L. Buonocore, et al. (1991). "Membrane fusion activity, oligomerization, 
and assembly of the rabies virus glycoprotein." Virology 185: 681-688. 
Whitt, M. A., L. Chong, et al. (1989). "Glycoprotein cytoplasmic domain sequences 
required for rescue of a vesicular stomatitis virus glycoprotein mutant." J Virol 
63: 3569-3578. 
Wild, C., J. W. Dubay, et al. (1994). "Propensity for a leucine zipper-like domain of 
human immunodeficiency virus type 1 gp41 to form oligomers correlates with a 
role in virus-induced fusion rather than assembly of the glycoprotein complex." 
Proc Natl Acad Sci USA 91(26): 12676-12680. 
Wiley, D. C. and J. J. Skehel (1987). "The structure and function of the hemagglutinin 
membrane glycoprotein of influenza virus." Ann Rev Biochem 56: 365-394. 
Wiley, D. C., I. A. Wilson, et al. (1981). "Structural identification of the antibody-
binding sites of Hong Kong influenza haemagglutinin and their involvement in 
antigenic variation." Nature 289(5796): 373-378. 
90 
Wilson, I., J. Skehel, et al. (1981). "Structure of the hemagglutinin membrane 
glycoprotein of Influenza virus at 3 A resolution." Nature (London) 289: 366-373. 
Wilson, I. A., J. J. Skehel, et al. (1981). "Structure of the haemagglutinin membrane 
glycoprotein of influenza virus at 3 A resolution." Nature 289(5796): 366-373. 
Wu, H., D. G. Myszka, et al. (1996). "Kinetic and structural analysis of mutant CD4 
receptors that are defective in HIV gp120 binding." Proc Natl Acad Sci U S A 
93(26): 15030-15035. 
Wu, M. M., M. Grabe, et al. (2001). "Mechanisms of pH regulation in the regulated 
secretory pathway." J Biol Chem 276(35): 33027-33035. 
Wyatt, R. and J. Sodroski (1998). "The HIV-1 envelope glycoproteins: fusogens, 
antigens, and immunogens." Science 280(5371): 1884-1888. 
Zagouras, P. and J. K. Rose (1993). "Dynamic equilibrium between vesicular stomatitis 
virus glycoprotein monomers and trimers in the Golgi and at the cell surface." J 
Virol  67: 7533-7538. 
Zagouras, P., A. Ruusala, et al. (1991). "Dissociation and reassociation of oligomeric 
viral glycoprotein subunits in the endoplasmic reticulum." J Virol 65: 1976-1984. 
Zhang, L. and H. P. Ghosh (1994). "Characterization of the putative fusogenic domain in 
vesicular stomatitis virus glycoprotein G." J Virol 68: 2186-2193. 
Zhang, X. L., J. R. Wang, et al. (2003). "[Expression, purification and identification of 
recombinant SARS coronavirus membrane protein]." Sheng Wu Hua Xue Yu 
Sheng Wu Wu Li Xue Bao (Shanghai) 35(12): 1140-1144. 
Zhao, H., B. Lindqvist, et al. (1994). "A tyrosine-based motif in the cytoplasmic domain 
of the alphavirus envelope protein is essential for budding." EMBO J 13: 4204-
4211. 
Zhu, P., J. Liu, et al. (2006). "Distribution and three-dimensional structure of AIDS virus 
envelope spikes." Nature 441(7095): 847-852. 
Zilberstein, A., M. D. Snider, et al. (1980). "Mutants of vesicular stomatitis virus blocked 
at different stages in maturation of the viral glycoprotein." Cell 21(2): 417-427. 
Zimmerberg, J., R. Blumenthal, et al. (1994). "Restricted movement of lipid and aqueous 
dyes through pores formed by influenza hemagglutinin during cell fusion." J Cell 
Biol 127(6 Pt 2): 1885-1894. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
91 
Vita 
 
 
Elizabeth Lane Matheny was born in Bluefield, West Virginia on September 16, 
1981 and primarily grew up in Ft. Myers, Florida.  She graduated from high school in 
May of 1999 and accepted a full tennis scholarship to attend The University of South 
Carolina Aiken where she majored in biology.  Upon graduation in May of 2003 with a 
BS in biology from The University of South Carolina Aiken she enrolled at The 
University of Tennessee Health Science Center in the department of Molecular Sciences.  
Subsequently, she joined the lab of Michael A. Whitt, Ph.D. for her doctoral research. 
Lane expects to graduate with a Ph.D. in Molecular Biology in December 2009. 
